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Abstract 
In most African communities, failure to lactate, like failure to ovulate, means failure to 
reproduce. Thus plant extracts are being used by African women to induce or stimulate 
milk production. 
An ethnobotanical survey has been carried out in the northern, central, eastern and 
southern parts of Burkina Faso. In total 79 informants (healers and village elders) and 217 
users from 22 villages were interviewed. This survey shows that the use of plants during 
lactation is common and that the indigenous people have a remarkable knowledge of 
species and their use as crude drugs. Ethnobotanical data on 90 plant species belonging to 
40 families, including medical use and traditional practices, were collected. Agalactia is 
the most common pathology after parturition, since 34% of the plants are used for 
induction of lactation. This survey pointed out seven species including Pennisetum 
americanum, Vitellaria paradoxa, Cadaba farinosa, Leptadenia hastata, Capsicum 
frutescens, Crateva adansonii, Acacia nilotica ssp adansonii to be widely used by women. 
The first six species are commonly used in human alimentation, albeit the latter appeared 
to be frequently used together with other plants for the treatment of a wide variety of 
diseases. Despite the widespread use of Acacia nilotica ssp adansonii in folk medicine, 
little is known about its actual pharmacological mechanism. 
In view of the traditional belief that Acacia nilotica ssp adansonii (AN) can stimulate milk 
production in lactating women, experiments were performed to determine the effect of an 
aqueous extract of AN on milk production in the rat. Female rats that received the AN 
extract orally during their first lactation, produced about 59% more milk causing an 
increase in pup growth compared to that in controls (P<0.01). Prolactin (PRL) is known to 
stimulate milk synthesis and secretion. Experiments were performed in peri-pubertal and 
adult virgin female rats to investigate the effect of AN on PRL synthesis and release. A 
strong relation between AN administration and PRL release after "acute" and "chronic" 
treatment has been observed in cycling female rats treated intravenously. PRL synthesis 
was also stimulated by AN extract in both adult and peri-pubertal animals albeit that in the 
latter group, estradiol-priming was needed for an efficient effect. The treatment with AN 
extract results in increased lobulo-alveolar structure development, filled with basophilic 
secretions and suppression of the terminal end bud development. AN extract stimulates the 
mammary gland growth and differentiation from the least differentiated structures to fully 
developed alveoli, showing active milk production. The mechanisms via which these 
processes occurred have been investigated. The treatment with bromocriptine (CB154), an 
agonist of dopamine significantly lowered pituitary- and plasma PRL levels compared to 
controls. A significant increase of pituitary PRL was observed in the group with 3g 
AN+CB154 as compared to CB154 alone although no significant change was found in 
plasma PRL. 
These results indicate that the AN-extract acts by stimulating the synthesis and release of 
PRL and probably other hormones, which in turn stimulate growth and differentiation of 
the mammary gland. AN-extract may also act directly on the mammary gland by 
stimulating the synthesis of milk components. Nevertheless further research is needed to 
elucidate the possible mechanism of action of AN-extract. 
Preface 
It is my great pleasure to express my thanks to God for all He has done in my life and 
especially for giving me good health, strength and determination during these years of 
study. To him, I return all the Glory and honour for this work. 
During my research period, many individuals and Institutions have contributed to the 
successful completion of the study. Special acknowledgement is due to Wageningen 
University for granting me the admission and facilitating my program both in Burkina 
Faso and in the Netherlands. Special acknowledgements also go to the University of 
Ouagadougou for allowing me to carry out the experiments in their laboratories and 
experimental sites. I would like to extend my thanks to all members of the Department of 
Systematic Botany of the University of Ouagadougou for their constant assistance in 
determining the plants collected during the field work. Special thanks goes to all the 
tradipraticians for their constant availability in teaching me the traditional knowledge and 
practices. 
With great pleasure and gratitude, I would like to thank the Sahel Project (Antenne 
Sahelienne) and the International Foundation for Science (IFS) for the additional funding 
to complete the study. 
My greatest respect goes to my first promoter, Prof. dr. Daan van der Heide for his 
intellectual stimulation, unlimited support and hospitality in every way from the inception 
to the completion of this thesis. I am deeply indebted to you. I am deeply grateful to my 
second promoter Prof. Laya Sawadogo for his special interest, professional and social 
guidance, unreserved support and encouragement. I honestly lack words good enough to 
describe all my appreciation, my Dad. 
I greatly appreciate the vital role played by dr. Eline van der Beek, my co-supervisor, for 
her valuable ideas and devotion to my work. You are always available for consultation and 
your critical discussions have made this work a success. I am sincerely grateful to Prof. 
Nianogo Joseph Aime, for his technical support and help and his invaluable comments 
during the writing of the thesis. 
Special thanks go to dr. John Mattheij for his invaluable input during the conceptualization 
of the proposal. I also wish to express my sincere thanks to dr. ir. Janny van der Elst for 
her hospitality, in which I was always welcome to her home and made to feel at home. I 
would like to extend my thanks to all members of the Department of Animal Physiology 
of the University of Ouagadoudou, and to all members of the Human and Animal 
Physiology Group of Wageningen University, for always being helpful and supportive. 
Thanks are due to all my colleagues in the Human and Animal Physiology Group and 
specially Hans Swarts and mrs. Hermien Bouwknegt-Doosje. I would also like to 
acknowledge drs. Ariella Magee-Karman, dr. Annelieke Schepens-Franke and ir. Harmke 
van Vugt for their support and their constant assistance when the going got tough. 
Special thanks to ir. Eddy Rijntjes and dr. Katja Teerds for helping with finalizing the 
thesis book. 
Finally, I am greatly indebted to my husband Martin and my children Stephanie and Andy 
for their support, encouragement, patience and understanding during my constant absence 
from them for the period of this study. 
Contents 
Chapter 1 General introduction 13 
Chapter 2 Plants and lactation: from indigenous knowledge and 25 
traditional practices 
Chapter 3 Acacia nilotica var adansonii (Mimosaceae) 43 
Chapter 4 Effects of aqueous extracts of Acacia nilotica ssp adansonii 49 
on milk production and prolactin release in rats 
Chapter 5 Effect of crude aquous extract oiAcasia nilotica var adansonii 63 
on cell proliferation and mammary gland differentiation 
Chapter 6 Mechanism of action of acacia extract in rat mammary gland 79 
differentiation 
Chapter 7 Summary and general discussion 91 
Nederlandse samenvatting 99 




For a long time, human milk was the only food for young babies. Human newborns are 
very immature at birth and thus totally dependent on their mother's milk for a varying 
time thereafter. However, during the last decade, major changes have occurred in infant 
feeding: from breast-feeding to bottle-feeding with either human milk or formulae based 
on cow's milk. It is well-known that the milk of each species is a unique complex 
secretion containing a large variety of components with special metabolic and nutritional 
functions, as mimicked at least in part by the wide variety of "humanized formula milk" 
on the market. Noticeably, it is widely accepted that breast-feeding is more than just 
nutrition. Fortunately, this assertion is reinforced since 1992 by the recommendations of 
the WHO and UNICEF for the practice of breast-feeding, even in developed countries. 
Recently, many aspects including prevention of infectious diseases and the increasing 
amount of information about the importance of mother-infant interactions on the 
psychology of the neonate have increased the necessity to reappraise the role of breast-
feeding in both developed and developing countries (Wright & Schanler 2001, Filteau 
2000, Ahiadeke 2000). Certainly, the benefits in terms of preventing the malnutrition-
infection cycle are especially great in developing countries (Brown et al. 1989). 
Consequently, the international policy (World Health Organization 1993) recommended 
that all infants should be exclusively breast-fed, i.e. not given any other foods or liquids 
including water for the first 4-6 months of life. Indeed, there is no doubt on the scientific 
basis of the importance of breast-feeding (Filteau 2000, Goldman 1993, Anderson et al. 
1999, Khin-Maung-U et al. 1985, and Sazawal et al. 1992). However, some apparently 
controversial evidence exists regarding the applicability of such recommendation in 
developing communities like in Africa, where breast-feeding is tightly linked with 
traditional medicine. 
African Traditional Medicine 
"African Traditional Medicine is not only use of plants but also all the practices, 
measures, ingredients and procedures of all kinds of materials or not, which from 
centuries and centuries had enabled the African people to protect themselves against 
disease, to cure themselves and to alleviate their sufferings. " (WHO 1973). 
Indeed, the use of natural products with therapeutic properties is as ancient as human 
civilisation. For a long time, minerals, animals, and plant products were the main sources 
of drugs. Although in developed countries, indigenous health care practices have been 
replaced by modern medicine, in developing countries, these practices are still the way of 
health care for the majority of the population, albeit that these tended to decline during the 
last few decades. However, an increased interest actually seems to reverse this trend. This 
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trend reversal is based on a need for new drugs in developed countries and on the fact that 
many modern drugs are beyond the reach of the majority of the population in developing 
countries, such as Burkina Faso, West Africa. Unfortunately, traditional knowledge has 
gradually changed. This alteration is due to the fact that the transmission of the knowledge 
is essentially oral and that traditional healers often pass away without having had the 
opportunity to hand down their knowledge, in addition to the progressive disappearance of 
useful plants caused by drought and deforestation. 
Having thus noted the impact of traditional medicine on health care in Africa, the 
necessity of officially integrating its activities into National Health Programmes is under 
discussion in most countries. An integration of the two types of medicine can only be most 
efficient when traditional medicine is well documented and the biological activities of the 
plants used are established. This raises a number of questions: 
1- What is the indigenous knowledge in medicinal plant use? 
2- What are the traditional practices and prescriptions? 
3- How many people have used these prescriptions? 
4- Are they efficient and safe? 
5- What are the mechanisms of action? 
One of the difficulties in answering these questions is that African traditional medicine 
appears to rely on cultural aspects. These cultural aspects are based on the concept that 3 
supernatural powers are at the origin of change in human well-being: The force of evil 
(sorcery), the gods, and the spirits emanating from ancestors which can be good or evil. 
The balance between good and evil spirits determines the health of the individual. Disease 
is regarded as a punishment for bad behaviour. Evil spirits can be chased away or 
appeased by certain procedures including the utilisation of certain plants. This is 
particularly true as far as reproduction is concerned. Plants from various habitats are 
traditionally used to stimulate libido and fertility, or to inhibit those during evil moon, to 
protect pregnant women from the evil eye, to inhibit or stimulate milk production etc. In 
the latter case, however, plant use during lactation has actually tended to decline due to 
new recommendations of the WHO (WHO 1992). Consequently, the significance of plant 
use during lactation in the African traditional communities might be worth reappraising. 
Breast-feeding in the African traditional community 
In most African communities, failure to lactate, like failure to ovulate, means failure to 
reproduce. Thus, breast-feeding implies more than just nutrition: it encompasses aspects of 
cultural, environmental, and psychosocial significance, operating between the mother and 
the baby as well as within the community. 
The traditional belief is that the newborn is a reincarnation of one of the ancestors of the 
family. The day, time, and conditions of birth are the indicators that will determine his 
given name and his destiny. Furthermore, an infant looks neither like his father nor his 
mother but resembles his grandfather or grandmother, particularly when the latter are 
deceased. Therefore, infringement of traditional rules during pregnancy is considered the 
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main cause of complications observed during parturition and leading to agalactia, 
hypoglactia, or mastitis and sometimes to the "return" (i.e. the death) of the infant. Since 
traditional medicine and breast-feeding are tightly interconnected, it is not surprising that 
breast-feeding is based on the same concept that supernatural powers lie at the origin of 
human well-being and that the newborn can be protected against evils by the 
administration of certain plants together with certain procedures. This concept may 
explain to some extent, that exclusive breast-feeding is rarely practiced in African 
communities (Shirima et al. 2001, Senanayake et al. 1999) where herbal tea is usually 
used during the first few days after birth. Indeed, maternal colostrum and milk have an 
important function as protective agents against infections in addition to their nutritional 
role. Early lack of maternal colostrum and milk in a sufficient quantity and quality might 
consequently affect early infant well-being and development, of which the latter 
determines its resistance against infections. Although 99% of the mothers are breast-
feeding in Burkina Faso, as well as in most of the developing countries, infant morbidity 
and mortality are still high. The confounding question is whether or not the high rate of 
infant malnutrition is due to the traditional practices or to insufficiencies in maternal milk 
quality and quantity. 
Indeed, health and nutrition are dramatically interconnected as evidenced by the 
drastically limited food resources in developing countries. Therefore, maternal 
malnutrition is thought to be the main, if not only, cause of infant feeding problems and 
early childhood malnutrition. Some reports show, however, that maternal undernutrition 
neither affected milk volume and energy levels (Rasmussen 1992, Perez-Escamilla et al. 
1995, Gonzalez-Cossio et al. 1998) nor immune factors (Miranda et al. 1983, Chang 1990, 
Herias et al. 1993, Lonnerdal et al. 1976, Prentice et al. 1983, Filtteau et al. 1999b). 
Reports on the relationship between maternal infection and lactational performance are 
controversial. Some investigations did not find any adverse effect of maternal infection on 
milk quality and quantity (Zavaleta et al. 1995), while others reported a dramatic decrease 
of lactational performance (Filteau et al. 1999a,b; Willumsen et al. 2000) associated with 
a low weight gain of the child (Filteau et al. 1999b), albeit that the bacteria from breast 
milk have been reported to be non-pathogenic for the infant. On the other hand, an infant 
from an HIV-infected mother can be infected during lactation. 
Many views regarding breast-feeding and traditional practices have been reported. 
Interestingly, in addition to limited access to modern formula milk, African women 
traditionally use plant extracts to induce and/or stimulate milk production. Lactation is a 
complex phenomenon encompassing multi-factorial processes including physiological, 
biochemical and structural changes of the mammary gland. Milk is consequently a 
complex product consisting mainly of sugars, lipids (mainly triglycerides), proteins (e.g. 
casein, lactalbumin) as well as many other factors regulating the immune function of the 
neonate (Bonati & Campi 2000). Based on new scientific information from biochemistry, 
immunology, nutrition, endocrinology, and psychophysiology about human milk and 
breast-feeding, the overall scheme of events that occurs in the mammary gland has been 
reviewed. This review is necessary to gain insight into the fundamental issue of the 
physiological adequacy of plant use in terms of induction and/or stimulation of lactation in 
women. 
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Mammogenesis and lactogenesis 
The ability to lactate depends on the presence of mammary glands, which is a typical 
feature of mammals. The mammary gland is part of the reproductive apparatus and 
lactation can be considered as the final phase of reproduction. Of subcutaneous origin, its 
number, shape and size vary greatly between species. Due to difficulties in the availability 
of tissue, normal development and differentiation of human breasts are rarely reported. 
Thus, the descriptive review reported here is based on rodent data. However, it is assumed 
that the overall patterns of growth and differentiation and the generation of various 
morphological structures are comparable between rodents and humans (Lydon et al. 2000, 
Shyamala 1999) (see Figure 1). 
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Figure 1 The overall pattern of mammary gland development and physiological targets of plant use during each stage of 
development. 
In rats, the mammary gland forms extensive subcutaneous sheets of tissue that extend 
from the cervical to the inguinal regions as six ventrolateral pairs, each with its own nipple 
(Russo & Russo 1978). The mammary gland of newborns is represented by a rudimentary 
duct system with small club-like ends that regress shortly after birth. In neonates of most 
species, there is an isometric duct growth of the mammary gland until before the onset of 
puberty, albeit that this period of growth has not yet been extensively studied in rodents. 
With the onset of puberty, the mammary gland undergoes allometric growth to establish 
the ductal elongation with terminal end buds (TEBs) prior to pregnancy (Cowie 1949). 
The first events of puberty are increases in circulating gonadotropin and estradiol (E2) 
levels associated with vaginal opening followed by vaginal cornification several days later 
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(Nelson et al. 1990). At puberty, the mammary gland consists of ducts with TEBs, which 
are the major site of proliferation (Monaghan et al. 1990) leading to the formation of 
terminal lobular units (Howard & Gusterson 2000) with the advancement of puberty. The 
epithelial-stromal interactions are the major components of ductal elongation. This ductal 
elongation and branching continue after puberty until the mammary fat pad is filled. The 
main characteristics of a mature mammary gland are the absence of terminal end buds and 
the presence of a highly branched architecture terminated by lobular buds (Horseman 
1999) in response to the hormonal change during the estrous cycle. During pregnancy, the 
lobular buds give rise to alveolar lobules, which increase both in size and number and 
reach maximal development at the end of pregnancy (Masso-Welch et al. 2000). 
Thus, lactation is a result of long physiological processes occurring in the mammary 
gland, mainly during pregnancy until the day of parturition. Indeed, mammary epithelial 
cells undergo secretory differentiation throughout the estrous cycle (Schedin et al. 2000), 
but pregnancy is required for final differentiation (Robinson et al. 1995). At the end of 
pregnancy, the mammary gland achieves a high rate of proliferation and a profound 
biochemical transformation within the epithelial cells which later leads to the synthesis of 
specific components of milk such as proteins (e.g. casein, lactalbumin), lipids (fatty acids) 
and sugar (e.g. lactose). During that period, the myoepithelial cell layer, which surrounds 
the alveolar epithelium, has acquired abundant cytoplasmic filaments for contractile 
function (Joshi et al. 1986) during lactation. 
Involution of the mammary gland following weaning is characterized by a rapid decrease 
in weight, volume and number of alveolar structures and in total DNA content, essentially 
due to the loss of cells by apoptosis (Strange et al. 1992, 1995, Walker et al. 1989). 
Hormonal regulation of mammogenesis and lactogenesis 
Extensive studies have clearly established that the developmental biology of mammary 
glands is very complex involving interactions between ovarian, adrenocortical and 
pituitary hormones (Nandi 1958, Kleinberg et al. 1990, Lyons et al. 1995, and Topper & 
Freeman 1980). Cyclical variations in cell proliferation and steroid receptor expression 
have been reported in the human breast (Olssen et al. 1996, Soderqvist et al. 1997) and in 
rat mammary tissue (Masso-Welch et al. 2000). Estrogen (E2) (Anderson et al. 1998) and 
growth hormone (GH) (Kleinberg et al. 2000, Sejrsen et al. 1999) are essential for 
mammary duct development. Progesterone (P) is essential for lobulo-alveolar 
development (Lydon et al. 2000, Shyamala 1999, and Fendrick et al. 1998) but not for 
ductal side branching as previously reported (Russo et al. 1991). Corticosteroids must be 
present for the ovarian steroids to exert their full effect. In contrast to the other hormones, 
recent reports show that prolactin (PRL) regulates mammary gland organogenesis from the 
primary duct system to the fully mature non-pregnant gland. It participates with placental 
lactogen in the differentiation of the lobuloalveolar system from the lobular buds, induces 
milk protein gene expression and finally stimulates lactation after delivery (Horseman 
1999). The ejection of milk requires the action of oxytocin (OX), secreted from the 
posterior pituitary in response to suckling. The milk stasis that occurs after weaning and 
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the decrease of lactogenic hormones, in particular PRL, are the main causes of involution 
of the mammary gland (Nguyen & Pollard 2000). However, the mechanisms involved in 
the regulation of mammogenesis and lactogenesis are still to be more clearly elucidated. 
PRL regulation of lactogenesis 
Identified by Riddle et al. (1931) and purified in 1933, PRL is a polypeptide hormone 
produced mainly in pituitary lactotrophic cells as well as in some peripheral tissues, 
including the mammary gland (Jonathan et al. 1996, Iwasaka et al. 2000). 
Pituitary PRL secretion is under hypothalamic control by both inhibitory and stimulatory 
factors (Freeman et al. 2000) although dominated by inhibitory factors (PIH), mainly 
dopamine, synthesized by the hypothalamus and released into the portal blood vessels. 
PRL down regulates its own secretion by increasing the release of PIH's in the portal 
system. 
Although more than 300 functions attributable to the hormone have been reviewed 
recently (Bole-Feysot et al. 1998), PRL has the specialised function of stimulating milk 
synthesis and secretion in mammals. In rats, PRL is secreted during early pregnancy in a 
diurnal and nocturnal pulse from the anterior pituitary (Andrews et al. 2001). The decrease 
in progesterone and estrogen levels after delivery allows PRL to exert its stimulatory 
action on the mammary gland epithelial cells and thus induce lactogenesis. It is unclear 
whether or not the inhibition of lactogenesis during late pregnancy, even though PRL 
levels are relatively high, is due to the high levels of estrogen or due to progesterone, 
which may act on the epithelial cell by decreasing PRL receptor numbers. Interestingly, 
PRL mRNA has been detected in rat mammary glands from mid to late pregnancy and 
throughout lactation (Iwasaka et al. 2000) and no 13-casein was detectable in the mammary 
gland of PRL receptor (PRLR) knock-out mice (Brisken et al. 1999). 
During established lactation, the suckling of the neonate stimulates PRL secretion. 
Continuous production of PRL is necessary for the maintenance of lactation, although no 
correlation was found between milk yield and plasma PRL levels (Cowie et al. 1980), 
suggesting that PRL may be more of a "survival factor" rather than a regulatory factor for 
milk secretion. 
In humans (Benedek-Jaszmann & Sternthal, 1976) and rodents (Cowie et al. 1969, Mena 
et al. 1982, and Flint et al. 1998), PRL is the major stimulus to milk synthesis. 
Bromocriptine (CB154), an analogue of dopamine that inhibits pituitary PRL secretion, 
completely suppresses milk yield in rats (Flint et al. 1998, Farmer et al. 1998, and Taylor 
& Peaker 1975). Yet, when milk production is almost completely inhibited by both CB154 
and a specific antiserum to rat GH, replacement therapy with GH partially restored milk 
production while replacement with PRL was fully effective (Flint et al. 1992). Other 
reports (Mena et al. 1982) have suggested the possible transformation of PRL into a 
presecretory PRL before it is secreted, and that dopaminergic control is exerted on the 
transformation-phase but not on the release-phase of the hormone. On the other hand, 
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drugs used for the treatment of psychological disorders such as sulpiride and 
perphenazine, stimulate PRL secretion and thus induce lactation. 
Causes of lactation disruption 
Indeed, lactation success depends on many factors. The change in systemic lactogenic 
hormone levels as reviewed above and the intra-mammary mechanisms of responsiveness 
to lactogenic hormones and milk removal are, in all species, at the origin of lactation 
defects. Mammary epithelial cell differentiation and proliferation are thought to be the 
primary determinants for milk production. Nutritional status at the time of puberty and 
during pregnancy, associated with a great variability of hormones in the maternal plasma 
has been reported to be critical to maximise mammary gland cell proliferation (Wilde et 
al. 1986, Park et al. 1989, Choi et al. 1997, and Kim et al. 1998). Moreover, lactation 
success depends on regular suckling of the neonate (Peaker & Wilde 1996). Without this 
stimulus, milk secretion stops and mammary involution is induced. Successful parturition 
under appropriate conditions may also influence lactation since in most cases stress is 
associated with an increase in PRL levels (Jeffcoate et al. 1986) as well as a decrease, 
particularly under conditions under which levels are normally high (Chatterton et al. 2000, 
Johansson et al. 1983). 
Possible ways of action of lactogenic plant extracts to induce and /or stimulate milk 
synthesis 
As reviewed above, PRL plays a key role in inducing and stimulating milk synthesis and 
maintaining lactation. PRL synthesised in the anterior pituitary is released into the portal 
vessel and transported to the mammary glands to stimulate milk synthesis. E2 increases 
the number of PRL-R whereas P suppresses this increase. PRL also upregulates its own 
receptors as an increase in PRL-R occurs at the time of the increase of plasma PRL levels 
at parturition. Therefore, the lactogenesis that occurs after parturition can be, to some 
extend, explained by the removal of the inhibition by P, and the stimulation of production 
of PRL-R by the increase of PRL itself. 
To this end, lactogenic plants may exert their effect by stimulating PRL synthesis in the 
anterior pituitary, increasing its release into the portal vessels, or increasing the number of 
PRL receptors on the mammary gland. The stimulatory effect of PRL on its own receptors 
was found to be discontinuous, as an increase of maternal circulating PRL levels during 
established lactation does not increase milk production. This indicates that the gland at this 
stage probably becomes less responsive to PRL, likely a result of the low number of PRL 
receptors on the mammary gland. This clearly suggests that the number of PRL-R at the 
beginning of lactation associated with the level of circulating PRL is essential for the 
maintenance of copious milk production. 
Lactogenic plants may also induce milk synthesis by acting directly on the mammary 
gland to stimulate mammary gland differentiation and cell proliferation, or by stimulating 
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mammary cell activity as milk production is related to mammary epithelial cell 
differentiation and proliferation. 
Outline of the thesis 
The aim of this study is to gain insight into the traditional beliefs and to provide scientific 
proof for the efficacy of lactogenic plants. 
This thesis focusses on (1) the plants used by women for the treatment of lactation 
deficiencies, (2) the biological effects of the plants used for induction and stimulation of 
lactation, and (3) the possible underlying mechanisms of action. For this purpose, 
information on plants with therapeutic properties was collected during field work, 
regarding which part of the plant is used, mode of preparation and administration, number 
of cases reported and number of people who have used these prescriptions (chapter 2). The 
ethnopharmacology, phytochemistry, and toxicology of Acacia nilotica ssp. Adansonii 
(AN), one of the plants widely used for induction and stimulation of lactation are 
addressed in chapter 3. In view of the traditional beliefs, experiments were performed to 
investigate the biological activity of an aqueous extract of AN in a rat model (chapters 4 
and 5). Finally, the mechanism via which AN-extract may act to achieve its biologic 
activities was explored (chapter 6). 
References 
Ahiadeke C 2000 Breast-feeding, diarrhoea and sanitation as component of infant and child health: a study 
of large scale survey data from Ghana and Nigeria. Journal ofBiosocial Science 32 47-61. 
Anderson E, Clarke RB & Howell A 1998 Estrogen responsiveness and control of normal human breast 
proliferation. Journal of Mammary Gland Biology and Neoplasia 3 37-48. 
Anderson TJ 1999 Pathological studies of apoptosis in the normal breast. Endocrine Related Cancer 6 9-12. 
Andrews ZB, Kokay IC & Grattan DR 2001 Dissociation of prolactin secretion from tuberoinfundibular 
dopamine activity in late pregnant rats Endocrinology 142 27' 19-2724. 
Benedek-Jaszmann & Sternthal V 1976 Late suppression of lactation with bromocryptine Practitioner 216 
450. 
Bole-Feysot C, Goffin V, Edery M & Binart N, Kelly PA 1998 Prolactin (PRL) and its receptor: actions, 
signal transduction pathways and phenotypes observed in PRL receptors knockout mice. Endocrine 
Reviews 19 225-268. 
Bonati M & Campi R 2000 Breastfeeding and infant illness American Journal of Public Health 90 1478-
1479. 
Brisken C, Kaur S, Chavarria T, Binart N, Sutherland RL, Weinberg Kelly PA & Ormandy CJ 1999 
Prolactin controls mammary gland development via direct and indirect mechanisms. Developmental 
Biology 210 96-106. 
Brown ML & Adelson SF 1969 Infant feeding practices among low and milde income families in Honolulu. 
Tropic Geographical Medicine 21 53. 
Brown KH & Bentley ME 1989 Dietary management of diarrhea. Mothers Child. 7 1-5. 
Chang SJ 1990 Antimicrobial proteins of maternal and cord sera and human milk in relation to maternal 
nutritional status. American Journal of Clinical Nutrition 51 183-7. 
Chatterton RT, Hill HP, Aldag JC, Hodges KR, Belknap SM & Zinaman MJ 2000 Relation of plasma 
oxytocin and prolactin concentration to milk production in mothers of preterm infants: influence of 
stress. The Journal of Clinical Endocrinology and Metabolism, 85 3661-3668. 
Choi YJ, Han IK, Woo JH, Lee HJ, Jang K, Myung KH & Kim YS 1997 Compensatory growth in dairy 
heifers: the effect of a compensatory growth pattern on growth rate and lactation performance. Journal of 
Dairy Science 80 519-24. 
21 
Cowie AT 1949 The relative growth of the mammary gland in normal, gonadectomized and 
adrenalectomized rat. Journal of Endocrinology 6 145-147. 
Cowie AT, Forsyth IA & Hart IC 1980 Hormonal control of lactation. Monograph of Endocrinology 15:1-
XIV, 1-275. 
Cowie AT, Hartmann PE & Turvey A 1969 The maintenance of lactation in the rabbit after 
hypophysectomy. Journal of Endocrinology 43 651 -62. 
Dietz WH 2001 Breastfeeding may help prevent childhood overweight. The Journal of the American 
Medical Association 285 2506-2507. 
Farmer C, Robert S & Rushen J 1998 Bromocriptine given orally to periparturient of lactating sows inhibits 
milk production. Journal of Animal Science 76 750-7. 
Fendrick JL, Raafat AM & Haslam SZ 1998 Mammary gland growth and development from the postnatal 
period to the postmenopause: Ovarian steroid receptor ontogeny and regulation in the mouse. Journal of 
Mammary Gland Biology and Neoplasia 3 7-22. 
Filteau SM 2000 Role of breast-feeding in managing malnutrition and infectious disease. The Proceedings of 
the Nutrition Society 59 565-572. 
Filteau SM, Lietz G, Mulokozi G, Bilotta S, Henry CJ & Tomkins AM 1999a Milk cytokines and subclinical 
breast inflammation in Tanzanian women: effects of dietary red palm oil or sunflower oil 
supplementation. Immunology 97 595-600. 
Filteau SM, Rice AL, Ball JJ, Chakraborty J, Stoltzfus R, de Francisco A & Willumsen JF 1999b Breast 
milk immune factors in Bangladeshi women supplemented postpartum with retinol or beta-carotene. 
American Journal of Clinical Nutrition 69 953-8. 
Flint DJ & Gardner M 1994 Evidence that growth hormone stimulates milk synthesis by direct action on the 
mammary gland and that prolactin exerts effects on milk secretion by maintenance of mammary 
deoxyribonucleic acid content and tight junction status. Endocrinology 135 1119-1124. 
Flint DJ & Vernon RG 1998 Effects of food restriction on the responses of the mammary gland and adipose 
tissue to prolactin and growth hormone in the lactating rat. Journal of Endocrinology 156 299-305. 
Flint DJ, Tonner E, Beattie J & Panton D 1992 Investigation of the mechanism of action of growth hormone 
in stimulating lactation in the rat. Journal of Endocrinology 134 377-383. 
Freeman ME, Kanyicska B, Lerant A & Nagy G 2000 Prolactin: Structure, function and regulation. 
Physiological Reviews 80 1523-1631. 
Gillman MW, Rifas-Shiman SL, Camargo CA Jr, Berkey CS, Frazier AL, Rockett HR, Field AE & Colditz 
GA 2001 Risk of overweight among adolescents who were breastfed as infants. Journal of the American 
Medical Association 285 2461-2467. 
Goldman AS 1993 The immune system of human milk: antimicrobial, antiinflammatory and 
Immunomodulating properties. Pediatrics and Infectious Disease Journal 12 664-71. 
Gonzalez-Cossio T, Habicht JP, Rasmussen KM & Delgado HL 1998 Impact of food supplementation 
during lactation on infant breast-milk intake and on the proportion of infants exclusively breast-fed. 
Journal of Nutrition 128 1692-702. 
Herias MV, Cruz JR, Gonzalez-Cossio T, Nave F, Carlsson B & Hanson LA 1993 The effect of caloric 
supplementation on selected milk protective factors in undernourished Guatemalan mothers. Pediatric 
Research 34 217'-21. 
Horseman ND 1999 Prolactin and mammary gland development Journal of Mammary Gland Biology and 
Neoplasia 4 79-88. 
Howard BA & Gusterson BA 2000 Human breast development. 5 Journal of Mammary Gland and Biology 
ofNeoplasia 5 119-37. 
Iwasaka T, Umemura S, Kakimoto K, Koizumi H & Osamura YR 2000 Expression of prolactin mRNA in 
rat mammary gland during pregnancy and lactation. Journal of Histochemistry & Cytochemistry 48 355-
362. 
Jeffcoate WJ, Lincoln NB, Selby C & Herbert M 1986 Correlation between anxiety and serum prolactin in 
human. JPsychosom res. 30 217-222. 
Jonathan NB, Mershon JL, Allen DL & Steinmetz RW 1996 Extrapituitary prolactin: distribution, 
regulation, functions and clinical aspects. Endocrine Reviews 17 639-669. 
Johansson GG, Karonen SL & Laakso ML 1983 Reversal of an elevated plasma level of prolactin during 
prolonged psychological stress. Acta Physiol. Scand. 119 463-464. 
22 
Joshi K, Ellis JTB, Hughes CM, Monaghan P & Neville AM 1986 Cellular proliferation in the rat mammary 
gland during pregnancy and lactation Laboratory Investigation 54 52-61. 
Kim SH, Moon YS, Keller WL & Park CS 1998 Compensatory nutrition-directed mammary cell 
proliferation and lactation in rats. British Journal of Nutrition 79 177-183. 
Khin Maung U & Greenough WB 3rd. 1991 Treatment of the dehydrated child. Pediatric Annual 20 7. 
Kleinberg DL Ruan W, Catanese V Newman CB & Feldman M 1990 Non-lactogenic effects of growth 
hormone on growth and insulin-like growth factor-1 messenger ribonucleic acid of rat mammary gland. 
Endocrinology 126 3274-3276. 
Lonnerdal B, Forsum E, Gebre-Medhin M & Hambraeus L 1976 Breast milk composition in Ethiopian and 
Swedish mothers. II. Lactose, nitrogen, and protein contents. American Journal of Clinical Nutrition 29 
1134-41. 
Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM & 
O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. 
Genes and Development 15 2266-78. 
Lydon JP, Sivaraman L & Conneely OM 2000 A reappraisal of progesterone action in the mammary gland. 
Journal of Mammary Gland Biology and Neoplasia 5 325-338. 
Lyons WR 1993 Hormonal synergism in mammary growth. Procedings of the Royal Society (London) 149 
303-325. 
Masso-Welch PA, Darcy KM, Stangle-Castor CN & Ip MM 2000 A developmental atlas of rat mammary 
gland histology. Journal of Mammary Gland Biology and Neoplasia 5 165-185. 
Mena F, Martinez-Escalera G, Aguayo D, Clapp C & Grosvenor CE 1982 Latency and duration of the 
effects of bromocriptine and prolactin on milk secretion in lactating rabbits. Journal of Endocrinology 94 
389-95. 
Miranda G, Anglade P, Mahe MF & Erhardt G 1993 Biochemical characterization of the bovine genetic 
kappa-casein C and E variants. Animal Genetics 24 27-31. 
Monaghan P, Perusinghe NP, Cowen P & Gusterson BA 1990 Peripubertal human breast development. 
Anatomical Record 226 501-8. 
Morton JA 1994 The clinical usefulness of breast milk sodium in the assessment of lactogenesis. Pediatrics 
93 802-6. 
Nandy S 1959 Hormonal control of mammogenesis and lactogenesis in the C3H/He Crgl mouse. University 
of California Publications in Zoology 65 1-128. 
Nelson JF, Karelus K, Felicio LS & Johnson TE 1990 Genetic influences on the timing of puberty in mice. 
Biology of Reproduction 42 649-55. 
Neville MC & Picciano MF 1997 Regulation of milk lipid synthesis and composition Annual Review of 
Nutrition 17 159-184. 
Neville MC 1983 Regulation of mammary gland development and lactation, In Neville MC & Neifert MR 
(eds), Lactation: Physiology, nutrition and breast-feeding. Plenum Press New York, pp 103-140. 
Neville MC, McFadden TB & Forsyth I 2002 Hormonal regulation of mammary differentiation and milk 
Secretion Journal of Mammary Gland Biology and Neoplasia 7 49-66. 
Nguyen AV & Pollard JW 2000 Transforming growth factor beta3 induces cell death during the first stage of 
mammary gland involution. Development 127 3107-18. 
Olssen H, Jernstrom H, Aim P, Kreipe H, Ingvar C, Jonsson PE & Ryden S 1996 Proliferation of the human 
breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors. Breast 
Cancer Research and Treatment 40 187-196. 
Park CS, Baik MG, Keller WL, Berg IE & Erickson GM 1989 Role of compensatory growth in lactation: a 
stair-step nutrient regimen modulates differentiation and lactation of bovine mammary gland. Growth 
Devlopment and Aging 53 159-66. 
Perez-Escamillia R, Cohen RJ, Brown KH, Landa Rivera L, Canahuati J & Dewy KG 1995 Maternal 
anthropometric status and lactation performance in low income Honduran population: evidence for the 
role of the infant. American Journal of Clinical Nutrition 61 528-534. 
Prentice MA, Paul AA, Prentice A, and Black AE, Cole TJ & Whitehead RG 1986 Cross-cultural 
differences in lactational performance. In Hamosh M and Goldman AS (eds.), Human Lactation 2, 
Plenum Publishing Corp., New York, p. 13-44. 
Rasmussen KM 1992 The influence of maternal nutrition on lactation. Annual Reviews in Nutrition 12 103-
17. 
23 
Riddle O & Braucher PF 1931 Studies on the Physiology of reproduction in Birds. Control of the special 
secretion of the crop-gland in pigeons by an anterior pituitary hormone. American Journal of Physiology 
97 617-625. 
Riddle O, Bates RW & Dykshorn SW 1933 The preparation, identification and assay of prolactin - a 
hormone of the anterior pituitary. American Journal of Physiology 105 191-216. 
Robinson GW, McKnight RA, Smith GH & Hennighausen L 1995 Mammary epithelial cells undergo 
secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal 
differentiation. Development 121 2079-2090. 
Russo IH & Russo J 1978 Developmental stage of the rat mammary gland as determinant of its susceptibility 
to 7,12-dimethylbenz(a)anthracene. Journal of the National Cancer Institute 61 1439-1449. 
Russo IH & Russo J 1991 Progestagens and mammary gland development: differentiation versus 
carcinogenesis. Acta Endocrinolica (Copenhagen) 125 Suppl 1 7-12. 
Russo J & Russo IH 1978 DNA labeling index and structure of the rat mammary gland as determinant of its 
susceptibility to carcinogenesis. Journal of the national Cancer Institute 61 1451-1457. 
Sazawal S, Bhan MK, Bhandari N. (1992) Type of milk feeding during acute diarrhoea and the risk of 
persistent diarrhoea: a case control study. Acta Paediatrica Supplement 381 93-7. 
Schedin P, Mitrenga T & Kaeck M 2000 Estrous cycle regulation of mammary epithelial cell proliferation, 
differentiation and death in the Sprague-Dawley rat: A model for investigating the role of estrous cycling 
in mammary carcinogenesis. Journal of Mammary Gland Biology and Neoplasia 5 211-225. 
Sejrsen K, Purup S, Vestergaard M, Weber MS & Knight CH 1999 Growth hormone and mammary gland 
development Domestic Animal Endocrinology 17 117-129. 
Senanayake MP, Weerawarna H, Karunaratne KW & de Silva TU 1999 Do Babies need water in Srli Lanka? 
Ceylon Medical Journal 44 126-129. 
Shah BH, Safdar B, Virani SS, Nawaz Z, Saeed SA & Gilani AH 1997 The antiplatelet aggregatory activity 
of Acacia nilotica is due to blockade of calcium influx through membrane calcium channels. Genetica 
and Pharmacology 29 251-5. 
Shirima R, Greiner T, Kylberg E & Gebre-Medhin M 2001 Exclusive breast-feeding is rarely practised in 
rural and urban Morogoro, Tanzania. Public Health Nutrition 4 147-154. 
Shyamala G 1999 Progesterone signaling and mammary gland morphogenesis Journal of Mammary Gland 
Biology and Neoplasia 4 89-104. 
Silberstein GB, Van Horn K, Shyamala G & Daniel CW 1994 Essential role of endogenous estrogen in 
directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. 
Endocrinology 134 84-90. 
Soderqvist G, Isaksson E, Schoultz B, Carsltrom K, Tani E & Skoog L 1997 Proliferation of breast epithelial 
cells in healthy women during menstrual cycle American Journal of Obstetrics and Gynecology 176 123-
128. 
Strange R, Friis RR, Bemis LT & Geske FJ 1995 Programmed cell death during mammary gland involution. 
Methods in Cell Biology 46 355-68. 
Strange R, Li F, Saurer S, Burkhardt A & Friis RR 1992 Apoptotic cell death and tissue remodelling during 
mouse mammary gland involution. Development 15 49-58. 
Taylor JC & Peaker M 1975 Effects of bromocriptine on milk secretion in the rabbit Journal of 
Endocrinology 67 313-4. 
Topper YJ & Freeman CS 1980 Multiple hormone interactions in the developmental biology of the 
mammary gland. Physiological Reviews 60 1049-1106. 
Walker NI, Bennett RE & Kerr JFR 1989 Cell death by apoptosis during involution of the lactating breast in 
mice and rats. American Journal of Anatomy, 185 19-32. 
Wilde CJ, Henderson AJ & Knight CH 1986 Metabolic adaptations in goat mammary tissue during 
pregnancy and lactation. Journal of Reproduction & Fertility 76 289-98. 
Willumsen JF, Filteau SM, Coutsoudis A, Uebel KE, Newell ML & Tomkins AM 2000 Subclinical mastitis 
as a risk factor for mother-infant HIV transmission. Adv Experimental Medical Biology 478 211 -23. 
Wright A & Schandler R 2001 The resurgence of breastfeeding at the end of the second millennium. The 
Journal of Nutrition 131 421S-425S. 
Zavaleta N, Lanata C, Butron B, Peerson JM, Brown KH & Lonnerdal B 1995 Effect of acute maternal 
infection on quantity and composition of breast milk. American Jouranl of Clinical Nutrition 62 559-63. 
24 
CHAPTER 2 
PLANTS AND LACTATION: 
INDIGENOUS KNOWLEDGE AND TRADITIONAL 
PRACTICES 
Lompo-Ouedraogo Z2, Van Der Heide D1, Nianogo AP 
'Human and Animal Physiology Group, Department of Animal Sciences, 
Wageningen University, The Netherlands 
HJnite de Formation et de Recherche en Sciences de la Vie et de la Terre, 
Universite de Ouagadougou, Burkina Faso 
25 
Abstract 
An ethnobotanical survey was carried out in the northern, central, eastern and southern 
parts of Burkina Faso inhabited by Yadse, Mosse, Gulmantse, and Bissa ethnic groups. In 
total 79 informants (healers and village elders) and 217 users from 22 villages were 
interviewed. Ethnobotanical data on 90 species belonging to 40 families including medical 
use and traditional practices, were collected. All women interviewed used plant 
medication to improve their milk production during several lactation periods; about 20% 
of the users used plants to stop ongoing lactation because of mastitis or death of the infant 
before weaning. Agalactia is the most common pathology after parturition since 34% of 
the plants are used for induction of lactation. This might be due to either the effect of 
socio-cultural factors or retention of placental fragments leading to blockage of the 
lactogenic hormone surge and thus to disruption of lactogenesis. Although only 1, rarely 2, 
plant is taken for inhibition, a mixture of at least 2 plants is always used for improvement 
of lactation, suggesting that some plants might be included just to inhibit the possible 
toxicity of some of the active plants. This study shows that the use of plants during 
lactation is common in the study area and that the indigenous peoples have a remarkable 
knowledge of species and their use as crude drugs. 
Introduction 
Based on the cases reported (Bognounou et al. 1975, Olivier-Bever 1982, Chenu & Ake 
1992, Gelfand et al. 1985, Nacoulma-Ouedraogo 1996, Van Wyk et al. 1997, and Ndubani 
& Hojer 1999) it can be stated that herbal medicine is still a method of health care in most 
African communities. 
With the advent of modern medicine, indigenous health care practices have tended to 
decline in importance during the past few decades, particularly in urban areas. However, a 
number of factors seem to have helped reverse this trend. Firstly, there is an increased 
interest in herbal medicine across the world (Elvin-Lewis 2001). Secondly, in Africa, most 
rural areas still lack functional health centers and many drugs are beyond the reach of the 
majority of the population. Indeed, modern medicine is more efficient for the treatment of 
specific diseases; however, modern medicine is still a luxury for the majority of Africans. 
In Burkina Faso, where 80% of the population lives in rural areas, there is a long tradition 
of using plant resources for basic needs, such as food, firewood, timber, and medicine. 
Plants from various habitats, such as forest, scrub, grassland and cultivated fields, are used 
as crude drugs (Ouedraogo 1984, Guinko 1977, 1984, Guinko & Bognounou 1982, and 
Bognounou et al. 1975, Nacoulma-Ouedraogo 1996). However, this inheritance is slowly 
disappearing due to the progressive disappearing of useful plants because of droughts, 
deforestation and overexploitation, as well as interruption of the line of transmission of 
knowledge. The transmission of knowledge is still essentially oral, from father to son (Van 
Wyk et al. 1997). However, with the new socioeconomic situation, sons often do not live 
with their parents anymore so that traditional healers pass away without having had the 
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opportunity to hand down their knowledge. In the present study we have attempted to 
document the plants used during all steps of reproduction (fertility, abortion, libido, 
lactation) in the northern, central and eastern parts of Burkina Faso (West Africa). In this 
paper, however, only plants used during lactation will be discussed. 
Materials and Methods 
The study area 
A field study was carried out in 5 provinces (Yatenga, Kadiogo, Kouritenga, Gourma, and 
Boulgou) of Burkina Faso (Figure 1). Yadse, Mosse, Mosse, Gulmatse, and Bissa ethnic 
groups inhabit these provinces, respectively. The landscape consists mainly of plains, 
between 200 and 400 m. above sea level. The climate of the area is tropical with a rainy 
season from June to October and a dry season from November to May. The annual rainfall 
in the study area is between 300 and 600 mm. The vegetation is characterised by thorny 
steppes, hardwood forests (acacia, anogeissus leiocarpus, crateva adansonii, adansonia 
digitata), shrubs and grasslands. 
Figure 1: Study area in Burkina Faso 
The survey 
Ethnobotanical information was gathered during field trips between 1997 and 1999. 
Interviews and discussions were carried out with local informants, i.e. traditional healers 
or "tradipraticians," village elders and rural women who are supposed to use these plants 
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(Table 1). A healer is someone who treats people by means of plants or any item 
associated with magic. A village elder, who is not necessarily the oldest person in the 
village, is the one to whom family knowledge is confided. For the interviews, a 
questionnaire was developed. The questions concerned the plants used, methods of 
preparation, mode of administration, traditional practices and perception of people with 
respect to certain related issues. At least three field trips were necessary to collect the 
information from each informant. The first was used to identify the people in the villages 
most suited for the interview. The second trip was to collect the information; interviews 
often lasted all night long, and sometimes, the interview could be recorded. During the 
third trip, information collected from the informants of a village was used to interview the 
women of that village. After each interview, voucher herbarium specimens were collected; 
specimens were later on identified taxonomically with the help of botanical references and 
by comparisons with identified specimens from the Department of Systematic Botany at 
the University of Ouagadougou, Burkina Faso. 
Results 
Informants and users 
A total of 296 people from 22 villages within the study area, including 261 females (16 
healers, 28 elders and 217 users) and 35 males (18 healers and 17 village elders) were 
interviewed (Table 1). In total 79 informants and 217 users were interviewed during the 
study. Of the informants, 89 % received the knowledge from their parents. The remaining 
11% (only men) acquired the knowledge from other sources (healers, self-learning or 
mystic revelation). Although village elders tend to specialize in a disease group (infant and 
maternal diseases, infant diseases, reproduction, female diseases, psychiatry, etc.), healers 
are super generalists whose healing relies mainly on the invocation of supernatural forces, 
in combination with plants or other items. 
Table 1: Composition of the informants and the users 
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times reported by women. Only plants mentioned by 5 informants or more are listed. 
Ethnobotanical data on 90 species with medicinal use, belonging to 40 families, were 
collected. Plants reported by the informants as being used for medical purposes are 
illustrated in Figure 2. Of the 90 species, 70 were mentioned by at least 10% of the 
informants, and 75 were used by at least one user. From the 75 species, 19 were used by at 
least 10% of the users; however, it appeared that the women did not use 15 species 
reported by the informants. 
• Plants used for induction and stimulation of milk production and its components 
As listed in Table 2, sixty-five plant species were reported for the induction and/or 
stimulation of lactation and improvement of milk quality. It was observed that more plants 
are used for induction (39 species) than for stimulation alone (6 species) or for the 
combination of stimulation and induction (7 species) of lactation. The use of plants for 
improvement of milk quality is more often associated with induction and stimulation (7 
species) than with induction alone (3 species) or stimulation alone (4 species). The 
improvement of milk quality is also often associated with the treatment of mastitis, as seen 
in Table 3. A change in milk quality due to mastitis was reported by at least 50% of the 
informants. Although at least 18 % of the users used plants to improve the quality of their 
milk, only 3 plant species belonging to 3 families were used. 
The most popular species for improvement of lactation were Pennisetum americanum 
(100%), Vitellaria paradoxa (58%), Cadaba farinosa (55%), Acacia nilotica ssp adansonii 
(50%), Leptadenia hastata (47%), Capsicum frutescens (46%), and Crateva adansonii 
(40%) (Figure 3). A plant is considered popular when reported by at least 50% of the 
informants and used by at least 40% of the users. 
• Plants used for inhibition of lactation and the treatment of mastitis 
Twenty plant species belonging to 16 families were listed as potent agents for the 
inhibition of lactation and/or the treatment of mastitis (Table 4). Of these 20 species, 10 
were used for the treatment of mastitis, 6 for the inhibition of lactation and 4 for both 
inhibition and mastitis. At the most, 20% and 24% of the users had used at least one plant 
for the treatment of mastitis and inhibition of lactation, respectively. The most popular 
plants for inhibition of lactation and/ or treatment of mastitis were Triumfeta cordifolia 




Figure 1 Medical purposes Figure 2 Plants used for improvement of 
lactation 
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(7%), Arachis hypogea (6%), and Bauhinia rufescens (5.5%) (Figure 4). A plant is 
considered popular when reported by at least 30% of the informants and used by at least 
5% of the users. 
Parts of the plant used and medicinal preparation 
Analysis of the ethnobotanical data shows that various plant parts are used, as illustrated in 
Figure 5. The most common parts are leaf (35%), stem with leaf (19%), bark (13%), root, 
rhizome and tuber (15%), fruit (8%), seed (5%), flower, latex and butter (5%). The 
collection of different parts of the plant is based on precise criteria. For instance, time 
(early in the morning, late in the afternoon), position of the moon and the sun (full moon, 
sunshine), birthday of the infant (on Monday) and the physiological state of the plant 
(stem with leaves, with or without flowers). 
Likewise, medicinal processing seems to depend on the part used, which in turn is related 
to the availability of the plant over the year and within the region. The most common 
medicinal preparations were maceration (induction, stimulation and milk quality), 
decoction (induction, stimulation and inhibition), fumigation (mastitis), paste (inhibition, 
mastitis and milk quality) and latex (mastitis). It was found that a mixture of at least 2 
plants was used for the induction and/or stimulation of lactation and its components, while 
only 1 or 2 plants were used for inhibition of lactation and or treatment of mastitis. 
I 
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Figure 4 Plants used for inhibition of Figure 5 The use of various plant parts 
lactation 
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Amaranthus spinosus L. 
Amaranthus viridis L. 
ANACARDIACEAE 
Ozoroa insignis Del. 
ANNONACEAE 
Annona senegalensis Pers. 
APOCYNACEAE 
Saba senegalensis (A.DC) 
Pichon var. senegalensis 
ASCLEPIADACEAE 


































Wedga leaf, fruit induction 
Decne. 
Leptadenia hastata (Pers.) 
Decne. 
Sarcostemma viminale (L.) 
R.Br. 
ASTERACEAE 





Vernonia colorata (Willd.) DrakeKoa-safande 
BASELLACEAE 
Basella alba L. 
BOMBACACEAE 
Adansonia digitata L. 
Bombax costatum Pellegr. & 
Vuillet 
Ceiba pentandra (L.) Gaertn. 
CAESALPINIACEAE 
Afzelia africana Smith ex Pers. 
Senna occidentalis (L.) Link 
Detarium microcarpum 
Guill. & Perr. 
Parkinsonia aculeata L. 
CAPPARACEAE 
Boscia senegalensis Pers. 














































































Maerua angolensis DC 
Crateva adansonii DC. 
CARICACEAE 














leaf, fruit, latex stimulatio 
COMBRETACEAE 
Guiera senegalensis J.F. Gmel. Wilin-wiiga leaf stimulation 
CONVOLVULACEAE 
lpotnea batatas (L.) Lam 
Ipomea eriocarpa R. Br. 
CUCURBITACEAE 
Luffa cylindrica (L) M.J. Roem 
Momordica balsamica L. 
CYPERACEAE 
Cyperus esculentus L. 
EUPHORBIACEAE 
Euphorbia hirta L. 
Euphorbia prostata Aiton 
Euphorbia pulcherrima Willd. 
ex Klotzsch 
Jatropha curcas L. 
Manihot esculenta Crantz. 
Phyllanthus niruri L. 
FABACEAE 
Cajanus cajan (L.) Millsp. 
Indigo/era tinctoria L. 
Stylosanthes erecta P. Beauv. 
LILIACEAE 
Asparagus flagellaris (Kunth) 
Baker 























Acacia nilotica (L.) .Willd. ex Del. var. adansonii 
(Guill. and Pers) 0 . Ktze 
Entada africana Guill. & Perr. 
Parkia biglobosa (Jacq.) 
R.Br, ex Benth. 
MORACEAE 
Ficus glumosa Delile 
Ficus ingens var. Ingensitalic? 
(Miq.) Miq. 
Ficus platyphylla Delile 
Ficus sur Forssk 







































































































































Andropogon gayanus Kunth. 
Pennisetum Glaucum (L.) 
(K. Schum.) (L.) R.Br. 
RUBIACEAE 
Crossopterix febrijuga 
(Afzel.ex G.Don) Benth. 
Feretia apodanthera Delile 
Spermacoce verticillata L. 
SAPINDACEAE 
Paullinia pinnata L. 
SCROPHULARIACEAE 
Scoparia dulcis L. 
SOLANACEAE 
Capsicum Jrutescens L. 
STERCULIACEAE 
Sterculia setigera Delile. 
VERBENACEAE 
Vitex doniana Sweet 
VITACEAE 

















































































Calotropis procera (Aiton) 
W.T. Aiton) Poussoumpuuga 6 1 
CAESALPrNIACEAE 
Bauhinia thonningii Schum. Baguin-gnaga 51 39 
LAMIACEAE 
Ocimum basilicum L. Yulumb-gnuuga 17 32 
POACEAE 
Sorghum bicolor (L.) Moench Kenn-da 
SAPOTACEAE 
Vitellariaparadoxa C.F. Gaertn. Taanga 
49 52 
41 125 
leaf, bark induction, 
root stimulation, 
mastitis 









stem, ear mastitis 
bark, butter induction, 
mastitis 
latex milk quality 
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Table 4: List of plants used for inhibition and/or mastitis 
Family/species Local Number Number Part 
Name of times of times used 
mentioned used by 





Pupalia lappacea (L.) Juss. Yong-tabdo 
BALANITACEAE 
Balanites aegyptiaca (L.) Delile Kieglega 
BIGNONIACEAE 
Stereospermum kunthianum ChamNin-yilenga 
CAESALPINIACEAE 
Bauhinia rufescens L. Tipohega 
Tamarindus indica L. Pousga 
COMBRETACEAE 
Anogeissus (eiocarpus (DC.) 





Combretum micranthum G. Don Randga 
Mogod-tiim 
CUCURBITACEAE 


















stem, leaf mastitis 
(Roxb. ex Willd.) Baill. 
Ricinus communis L 
FABACEAE 
Arachis hypogaea L. 
Vigna unguiculata (L.) Walp. 
LAMIACEAE 
Hyptis suaveolens Poit. 
MORINGACEAE 
Moringa oleifera Lam. 
NYMPHAEACEAE 
Nymphaea lotus L. 
PASSIFLORACEAE 











































Andropogonpinguipes (Stapf) Koulmoodo 
RHAMNACEAE 
Ziziphus mauritiana Lam. 
VERBENACEAE 
Vitex diversifolia Baker 
Mougounuga 
TIL1ACEAE 
Triumfetta cordifolia A. Rich. Natoukouli 
Napug-aadega 
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stem, leaf mastitis 





Table 5 List of the most popular plants used for improvement of lactation 
Family/species Local name No of times 
mentioned by the 
respondents 
(N = 79) 
No of times 
used by the 
women 
(N = 217) 
Part used Medical 
use 
ASCLEPIADACEAE 
Leptadenia hastata (Pers.) Lelongo 
CAPPARACEAE 
Cadaba farinosa Forssk. 
Crateva adansonii DC. 
MIMOSACEAE 
Acacia nilotica (L.) Willd.ex 
Del. var. adansonii 
(Guill. & Perr.) O. Ktze 
POACEAE 
Pennisetum g/ucaum (L.) R. Br. 
SAPOTACEAE 
Vitellaria paradoxa C.F. Gaertn. 
SOLANACEAE 











































Traditional practices are based on the concept that supernatural powers lie at the origin of 
human well-being: the forces of evil, the gods, and the spirits emanating from the 
ancestors who can be good or evil. The balance between good and evil spirits determines 
the health of the individual. Disease is regarded as a punishment for bad behaviour. Evil 
spirits can however be appeased by the administration of certain plants together with 
certain procedures. 
Induction 
According to traditional perceptions, agalactia occurs in women who do not comply with 
traditional rules (for instance, eating foods normally prohibited by local customs) during 
their pregnancy. In some areas, physical treatment is applied to the breast before the use of 
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any plant. The breast is massaged with the butter of Vitellaria paradoxa. After this 
massage therapy, a mixture of plants is administrated for the induction of lactation. Some 
of the popular prescriptions are listed below. 
1 - Fresh leaves of Acacia nilotica ssp adansonii are boiled in water. The decoction is 
mixed with the powder of the seeds of Pennisetum americanum and drunk all day long. 
Lactation occurs within 2 days. 
2 - Fresh leaves of Acacia nilotica ssp adansonii and Crateva adansonii are crushed in a 
mortar. The paste is mixed with water and filtered (for dry leaves, the decoction is used). 
The seeds of Pennisetum americanum are crushed together with a few fruits of Capsicum 
frutescens and a bit of salt. This powder is mixed with a bit of butter of Vittelaria 
paradoxa to obtain a paste. This paste is then mixed with the filtrate obtained above and 
drunk throughout the day. The treatment may be repeated the following day, if necessary. 
This mixture is reported to induce lactation in non-lactating women. Many variants of this 
recipe are known, based on 1 to 3 of the following plants: Cadaba farinosa, Leptadenia 
hastata, Acacia nilotica ssp adansonii and Crateva adansonii in association with 
Pennisetum americanum, Capsicum frutescens and Vittelaria paradoxa. 
Stimulation 
Hypogalactia is considered to be a result of non-observation of traditional rules, only 
rarely due to "natural" reasons, and occurs about 4 to 6 months after parturition. 
As reported by the informant, clinical symptoms observed in the case of hypogalactia are 
the lack of growth and the continuous cries of the breast-fed infant. In most cases, the 
latter is the main sign for the mother. For treatment, one mixture of plants is given to the 
infant to stimulate his appetite and to make him grow faster and stronger, while another 
mixture is given to the mother. 
1 - Fresh leaf-bearing stems of Piliostigma thonningii are crushed in a mortar with the 
powder of Pennisetum americanum seeds. Fresh leaf-bearing stems of Leptadenia hastata 
are boiled in water and filtered. The filtrate is added to the paste and drunk throughout the 
day. 
2 - Fresh bark from the East and West sides of the tree Parkia biglobosa is macerated 
overnight. The macerate is mixed with powder of the seeds of Pennisetum americanum 
and drunk on an empty stomach (early in the morning). 
3 - Immature fruits and/or fresh stems with leaves of Saba senegalensis are crushed in a 
mortar with seeds of Pennisetum americanum. The paste is mixed with a macerate of fruits 
of Adansonia digitata and drunk throughout the day. The treatment is continued for 3 days 
(for a male infant) or 4 days (for a female infant). 
4 - Fresh stems with leaves of Guiera senegalensis (collected late in the afternoon) and a 
stem with leaves of Euphorbia hirta are crushed in a mortar and mixed with the powder of 
Pennisetum americanum. The paste is then macerated in water and drunk all day long. The 
treatment is continued for 14 days. Only a decoction of Guiera senegalensis is used 
together with the powder of Pennisetum americanum. 
Milk quality and mastitis 
Clinical symptoms observed by the informant which indicate low content of milk 
components during lactation are lack of growth, diarrhoea, continuous crying and 
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vomiting of the infant, and swelling of the mother's breast. For the diagnosis, the "ant 
test" is used: an ant is put in a small quantity of the mother's milk; drowning of the ant 
means the milk is not good. The prescriptions listed below are then used for treatment. 
1 - For improvement of milk quality, a paste is cooked from powderised Sorghum bicolor. 
A small quantity of this paste is added to leaves of Piliostigma thonningii and boiled in 
water. The potage is used to wash the breast. The filtrate is drunk all day for 3 (for a male 
infant) or 4 days (for a female infant). 
2 - For mastitis, fruits of Piliostigma thonningii are burned in a traditional pot. The ash is 
mixed with butter of Vitellaria paradoxa and applied to the breast. The same paste is also 
used to increase milk lipid content. 
Inhibition and mastitis 
Women use plants to inhibit their milk production mainly in the case of abortion or loss of 
the infant before weaning. 
1 - Fresh leaves of Anogeissus leiocarpus are boiled in water and drunk during a period of 
7 days on an empty stomach. 
2 - Fresh leaves of Combretum micranthum are boiled in water and drunk during a period 
of 7 days. 
3 - Fresh leaves or seeds of Vigna unguiculata are crushed in a small traditional pot. The 
paste is then applied to the breast each day during a period of 3 to 7 days. 
Discussion 
The present study clearly demonstrates that inhabitants of various parts of Burkina Faso 
use plants for their health care, as previously reported (Nacoulma-Ouedraogo 1996, 
Guinko 1984, 1977, and Bognounou et al. 1975). This is particularly true as far as 
lactation is concerned. Interestingly, not only all women have used at least one plant for 
either induction or stimulation of lactation, but the plants used appear to be similar within 
the study area as well. Eleven species were widely used by women for the treatment of 
agalactia and / or hypogalactia, seven of which were used by at least 40% of the users 
throughout several lactation periods. Although a mixture of at least 2 plants is used for 
induction and stimulation in all the prescriptions, such mixtures rarely exist for inhibition 
of lactation and treatment of mastitis where the number of plants used is 2 or less. 
Evidence exists that certain drugs can be transmitted to the infant through breast milk 
when mothers use herbal remedies during lactation (Elvin-Lewis 2001); some of these 
drugs may be fatal for the infant. It seems likely that while some of the plants in a given 
treatment mixture induce or stimulate lactation, other plants may be added to the same 
mixture to inhibit the possible toxicity of active plants and to prevent intoxication of both 
mother and infant. Moreover, widespread use of a given plant within a village community 
is generally based on long-term observations of its efficacy (pharmacological effects) and 
its safety for mother and infant (toxicological effects). However, variations were observed 
not only in species and number of plants used, but also in parts used; such variations may 
37 
be due to either availability of the plant over the year or to variations in soil nutrient 
composition. 
On the other hand, it appeared that plants were often used for inhibition of lactation and 
treatment of mastitis, even if only a maximum of 23 cases were reported, suggesting that 
at least 10% of the women had been obliged to stop an ongoing lactation. However, the 
exact causes of infant death or mastitis are still not known. 
The traditional belief is that the newborn is a reincarnation of one of the ancestors of the 
family. The day, time, and conditions of birth are the indicators that will determine his 
given name and his destiny. Furthermore, an infant looks neither like his father nor his 
mother but resembles his grandfather or grandmother, particularly when the latter are 
deceased. Therefore, infringement of traditional rules during pregnancy is considered the 
main cause of complications observed during parturition and leading to agalactia, 
hypoglactia, or mastitis and sometimes to the "return" (i.e. the death) of the infant. 
Lactation is the result of extensive physiological processes occurring in the mammary 
gland during pregnancy until the day of parturition (Martinet & Houdebine, 1993). Indeed, 
growth and development of the mammary gland during pregnancy and the hormonal 
interactions occurring during parturition are indispensable for the onset of milk 
production. At parturition, the abrupt decrease in both progesterone and estrogen levels 
associated with the abrupt increase in PRL level and the increase in glucocorticoid and 
oxytocin levels lead to the onset of lactation. Lactation is in fact a combination of milk 
secretion (mainly regulated by PRL) and milk removal (regulated by stimulation of the 
nipple by the infant). 
Comparison of the number of plants used for induction (39 species) with the total clearly 
shows that agalactia is the most common pathology occurring after parturition in the study 
area. Three key suggestions can be made: 
Firstly, the conditions of birth such as maternal stress 2-5 days after labour, as often occurs 
in primiparae, may affect the onset of lactation. Indeed, the stress response is not only 
associated with increased PRL levels (Jeffcoate et al. 1986) but also with decreased PRL 
levels (Chatterton et al. 2000, Johansson et al. 1983), particularly under conditions in 
which its levels are normally high. Some cultural and social factors, such as food taboos 
might have been introduced to reduce the stress- induced problems during parturition. 
Although some explanations of food taboos such as "the child will become a thief when 
the mother eats eggs during pregnancy" are unsubstantiated, others are based on the 
general claim that a small baby is easier to deliver than a big one. For that reason, it is in 
fact a taboo to eat energy-rich food during pregnancy to prevent excessive growth of the 
baby. Since neither traditional midwives nor modern medical assistants, if present, have 
any surgical training and/or equipment, traditional ways of controlling food intake during 
pregnancy must be sustained. Moreover, 70 to 80% of the pregnant women living in towns 
(pers. comm.), mainly primiparae, undergo surgical incision of the vagina during delivery, 
not being exposed to the obligation of following traditional rules. The lack of such 
equipment and knowledge in the villages may to some extent explain the high maternal 
and neonatal mortality rates, in addition to the abusive use of abortive plants in these 
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particular cases. On the other hand, pregnant women have restricted access to calories and 
specific nutrients during some periods when the food supply is inadequate, thus affecting 
the course of pregnancy and thereby the onset of lactation. Although food taboos may be 
based on prolonged experience when they relate to pregnant women, chances are most of 
them are based on superstition when they relate to lactating women. 
Secondly, incomplete delivery of the placenta after parturition may occur, leading to 
blockage of the PRL surge and consequently to alterations in the onset and maintenance of 
lactation, as previously reported by Anderson (2001). This suggestion is quite plausible 
since the induction of lactation occurs within one day of treatment with the extract of a 
plant used for both parturition and delivery of the placenta. It should be noted that some of 
the plants used for parturition and delivery of the placenta are also used in other African 
countries, as an abortive (Noumi & Tchkonang 2001). 
Thirdly, decreasing progesterone levels can stimulate copious milk secretion only in the 
presence of lactogenic hormones, in particular PRL (Austin & Short 1984). Moreover, not 
only a certain level of circulating PRL is needed, but mammary gland PRL receptors must 
also be sufficiently present and functional, inducing the effect of PRL on the mammary 
gland cells and thus stimulating milk synthesis. Some plants, such as Acacia nilotica ssp 
adansonii, have been reported to stimulate PRL release in ewe and rat (Sawadogo 1987). 
These observations suggest that a mixture of Leptania hastata(which is used as abortive) 
and Acacia nilotica ssp adansonii could induce milk production; however, their effects on 
the mammary gland have not yet investigated. Maternal milk yield is regulated by the 
demands of the infant (Perez-Escamilla et al. 1995, Prentice et al. 1986), which are in turn 
a function of the energy content of the milk (Villalpando et al. 1999). However, milk 
secretion requires adequate levels of circulating PRL since the inhibition of PRL secretion 
and its release after treatment with bromocriptine led to inhibition of milk secretion 
(Martine/ al. 1981). 
It can be concluded from this survey that all women in the study area have used plant 
extract during lactation and a mixture of plants is always used to improve lactation for the 
infant. As far as traditional practice is concerned, we hypothesise that components of the 
plant used for improvement of milk production could have a direct effect by stimulating 
mammary secretory cells and/or an indirect effect by stimulating the secretion and release 
of lactogenic hormones, in particular PRL. Likewise, plants used for inhibition of lactation 
may have an indirect effect by inhibiting the secretion and release of PRL, which would 
lead to the interruption of lactation, and a direct effect on the activity of secretory cells 
since some of the plants are applied directly onto the mammary gland as pastes. However, 
there is no scientific proof of the traditional belief that these plants can effectively 
stimulate milk production. Further investigation will be necessary to identify plants with 
active components, the exact effects of these components, and their mechanisms of action. 
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Introduction 
The genus Acacia (Mimosaceae) contains several species distributed in dry regions of 
Africa (Barnes et al. 1996, Guinko 1992), from Egypt and Mauritania southwards 
(Woldemeskel et al. 1998) to South Africa (Dube et al. 2001). Seventeen species are 
present in Burkina Faso (Guinko 1992) three of which, Acacia nilotica var. adansonii, 
Acacia nilotica var. nilotica and Acacia nilotica var. tomentosa are remarkably distributed 
from the northern to the eastern part of the country. According to Kerharo & Adam 
(1974), Acacia nilotica var. adansonii (Guill. et Perr.) O. Ktze is a thorny tree of 10-12 m 
of length or less, with dark gray bark color, green gray-leaves and golden flowers. 
Apart from differences between the forms of the pods and in some areas the color of the 
trunk, these three species that resemble eachother qua foliage and inflorescence have 
nearly the same systematic characteristics. The systematics of Anilotica species is 
confusing and most of the time it has been described as Acacia arabica Willd. or as 
Acacia nilotica Del. (Kheraro & Adam 1974). Moreover, the possible hybridisation 
(pollination by bees) and the constant change (with age) of the shape of inflorescence and 
colors of their flowers makes the determination of Acacia nilotica subspecies difficult. 
People in the villages however, are able to distinghuish between these 3 species. The local 
names of Acacia nilotica ssp adansonii are "Pegnenga" for Yadse and Moose people, 
"Konbonkarga" for Gourmantse and "pelinga go" for Bissa people. Acacia nilotica var. 
adansonii (AN) and thus all the acacia species, is a multipurpose tree that plays a key role 
in rural development. AN is a source of various products including firewood, charcoal, 
timber, fodder, seeds for human nutrition, gum and pods for dye and tannin. In addition to 
its role in rural economy, AN provides good restoration of soil fertility, and plays an 
important role in soil conservation (Guinko 1992, Barnes et al. 1996). 
Apart from its importance in rural population survival and its role in the regulation of the 
ecosystem, Acacia nilotica var. adansonii is widely used in folk medicine for the treatment 
of various diseases. In the traditional context, a widespread use of a plant relies on a long-
term observation of its efficiency and safety. Its multiple therapeutic properties however, 
are still poorly explored. Indeed, research and development of therapeutic properties from 
a plant is a multidisciplinary process (Verpoorte 1989) involving botany, pharmacology, 
phytochemistry, toxicology and biology and may explain, to some extent, the lack of 
scientific information on African traditional medicine. In this chapter, the 
ethnopharmacology, phytochemistry, and toxicology of Acacia nilotica var. adansonii are 
presented. This information may provide a basis for understanding its multiple therapeutic 
uses and its biological activity in the particular case of lactation. 
Ethnopharmacology and biological activities 
Several plants with therapeutic properties regarding lactation related defects have been 
reported (see chapter 2) with Acacia nilotica var. adansonii being one of the six plants 
widely used for induction and stimulation of lactation. Apart from this, Acacia nilotica 
var. adansonii appears to be used and / or frequently associated with other plants in parts 
of Burkina Faso for the treatment of a wide variety of diseases (Personal observation). The 
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bark and/or pods are frequently associated in preparations for the stimulation of libido and 
fertility. Decoctions from leaves and bark are widely used to treat infant diarrhoea and to 
prevent infants from infections that occur during weaning. Acacia nilotica ssp adansonii is 
said to be able to regenerate necrotic tissue and to "firm up" a withered breast. Nacoulma-
Ouedraogo (1996) reported astringent, antiseptic, anti-inflammatory, hemostatic and tonic 
properties of a tea prepared from its leaves, flowers, seed and bark. Decoctions or powder 
of leaves and bark were applied externally in case of leprosy and mouth lacerations. In 
Niger, the seeds are preferentially used for induction and stimulation of lactation (Guinko 
1992). Likewise, Acacia nilotica species have been reported to have anti-hyperglycemic 
(Akhtar & Khan 1985), anti-microbial (Sotohy et al. 1997, Abd-El-Nabi 1992), anti-
plasmodial (El-Tahir et al. 1999), anti-inflammatory, analgesic and anti-pyretic (Dafallah 
& al-Mustapha 1996) properties. The methanol extract of the pods of Acacia nilotica ssp 
showed anti-hypertension activities (Gilani et al. 1999) while aqueous extract of the seeds 
exhibited spasmogenic and vasoconstrictive actions (Amos et al. 1999). Acacia nilotica 
subspecies are traditionally used in Pakistan for the treatment of diarrhoea and Shah et al. 
(1997) recently uncovered their anti-platelet aggregation activity. Methanol (bark and 
pods) and aqueous (pods) extract of Acacia nilotica showed considerable inhibitory effects 
to HIV-1 protease (Hussein et al. 1999) and hepatitis C virus protease (Hussein et al. 
2000). 
Phytochemistry 
The phytochemistry of Acacia nilotica has received great interest, mainly because of the 
use of its tannins for industrial pruposes. However, a number of phytochemical reports do 
not specify the variety investigated, which is mainly due to the fact that these three 
varieties had been described as Acacia nilotica Del. pers. 
Phytochemistry (method of Ciulei 1982) of the leaves of Acacia nilotica var. adansonii 
performed in the northern, central and eastern parts of Burkina Faso revealed the presence 
of polyphenols (tannins), anthracenosids, coumarinic derivatives, cardiotonic glycosides, 
flavonoids, steroids, and terpenoids (Table 1). The aqueous extract is rich in glucids 
including rhamnose, arabinose, galactose and also rich in uronic acids such as galacturonic 
acid. None of those -oses, however, have been found to stimulate PRL release in the ewe 
apart from pectin and oligogalacturonic acid (Sawadogo 1987, Sepehri et al. 1990). 
The extract from the leaves, roots and bark of Acacia nilotica ssp contains 18-20% of 
tannins (Kerharo & Adam 1974). The bark of the roots of Acacia nilotica ssp adansonii 
contains up till 36% of tannins. The presence of saponosids has also been reported, but a 
haemolytic test was found to be negative. Acacia nilotica leaves also contain 
proanthocyanidins and other phenolics (Dube et al. 2001). 
Toxicology 
From the ethnobotanical survey it follows, that women have used Acacia nilotica var. 
adansonii for generations without any reports of pathologic effects. In addition, we did not 
observe any clinical toxicity in rats treated orally with increasing doses (3, 3.5, 4, 4.5, 5, 
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5.5, 6g/kg) of aqueous extract of leaves of this plant (this thesis), although tannins have 
been reported to be potentially toxic to ruminants (Reed 1995). The intra-muscular 
injection, however, caused an inflammatory effect in the area surrounding the injection 
point in rats. We have also observed a claustration of the animal after intravenous injection 
of either extract (2-5 min) or saline (2-3 min). Likewise, the extract did not inhibit 
intestine peristalsis in vitro and no apparent toxicity was observed in rats and ewes treated 
orally with the extract, although a meteorisation after i.v. treatment has been reported in 
ewes (Sawadogo 1987). Al-Mustafa & Dafallah (2000) reported a significant decrease in 
body weight and in levels of hemoglobin, serum total protein and total cholesterol in rats 
fed a diet containing 8% of Acacia nilotica for up to 4 weeks. No death or 
histopathological changes in the liver were observed. On the other hand, a methanol 
extract of roots of Acacia nilotica has shown cytotoxic activity in vitro (Kamuhabwa et al. 
2000). 
Conclusion 
Regarding its multiple use in traditional medicine, Acacia nilotica might be compared to 
aspirin in modern medicine. Despite its widespread use in folk medicine in the treatment 
of various diseases, little is known about its biological effects. Given that 90% of the 
women in Africa are breast-feeding, and that a lot of them may have lactation-related 
defects, Acacia nilotica appears to be an attractive source of new therapeutic compounds 
in the improvement of lactation in a low income population. It is currently not known 
whether or not Acacia nilotica may effectively induce or stimulate lactation in women. 
Further studies will elucidate potential stimulatory effects, and possible mechanisms of 
action in rats. 
Table 1: Phytochemistry of leaves of Acacia nilotica var adansonii 
Anthocians Coumarins Flavonoids Glucids Quinones Saponosids Steroids Tannins 
Triterpene 
Aqueous . . . +++ +/. . ++ 
Extract 
Ethanolic + + + + + + + + + + - ++ 
extract 
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Abstract 
In view of the traditional belief that Acacia nilotica ssp adansonii (AN) can stimulate milk 
production in lactating women, experiments were performed to determine the effect of an 
aqueous extract of AN on milk production in rats. Female rats that received oral doses 
(280 or 560 mg) of aqueous extract of this plant during their first lactation produced about 
59% more milk compared to controls (P<0.01). Pup weight gain was also significantly 
higher compared to that in the control group. A lower dose, i.e. comparable to that used by 
women to improve their milk yield, led to about 33% more milk volume with the same 
growth rate for pups compared to the high dose group. The extract of AN was found to 
stimulate synthesis and release of PRL significantly (PO.05). In addition, mammary 
glands of estrogen-primed rats treated with the extract showed clear lobulo-alveolar 
development with milk secretion. This study demonstrates that aqueous extract of AN can 
stimulate milk production and PRL release in the female rat and could consequently have 
the properties claimed for by lactating women. 
Introduction 
African women with milk production deficiencies traditionally use plant extracts to induce 
milk production or to increase milk yield. With limited access to modern milk replacers, 
breast-feeding is essential for the survival of the newborn. Most plant extracts are 
generally used in the form of decoction or maceration. The floristic and ethnobotanic 
aspects of lactogenic plants have been studied extensively (Adjanohoun et al. 1979a, 
1979b; Bognounou et al. 191 A, Nacoulma-Ouedraogo 1996); however, little is known 
about their biological activities. On the other hand, the positive effect of Asparagus 
racemosus extract on milk production in buffaloes has been reported, (Patel & Kanitkar 
1969). Some plants have been identified as lactogenic because of a capacity to stimulate 
the synthesis of lactogenic hormones (PRL, growth hormone, Cortisol) and/or B-endorphin 
and 13-casein accumulation in the mammary gland in vivo and in vitro (Sawadogo et al. 
1987, 1988a, 1988b, 1988c). Indeed, PRL is known to play a key role in mammogenesis 
and lactogenesis (Zwierzchowski 1993, Hennighausen et al. 1997, Horseman 1999, 
Brisken et al. 1999, and Llovera et al. 2000) in all species, including the rat. However, for 
PRL to exert its mitotic effects, the tissue must be exposed to estrogen (Martal et al. 
1982). In rodents, initiation of lactation has the obligate requirement of PRL (Knight et al. 
1986, Madon et al. 1986). After parturition, PRL induces lactation by direct stimulation of 
synthesis of milk proteins in epithelial cells and by indirect stimulation of proliferation of 
secretory cells. However, growth hormone (GH) is needed to support milk production 
when PRL is reduced (Flint et al. 1992). A few plants have been described that stimulate 
PRL release (Sawadogo 1987) or milk production (Patel & Kanitkar 1969) or mammary 
gland development (Sabnis et al. 1969). However, an exact relationship between these 
effects for a given plant has not yet been established. In view of the claim that AN is 
frequently used traditionally to improve lactation, experiments were performed to 
determine whether AN can stimulate milk production, PRL release and mammary gland 
development in rats. 
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Materials and Methods 
Preparation of Acacia nilotica ssp adansonii (AN) extract 
According to tradition, a nursing woman (± 65 kg) drinks an extract of about lOOg dry AN 
leaves per liter per day. For our experiments, AN fresh leaves were air-dried in shade and 
pulverized, then boiled in water for 15 min (1:4 w/w). After centrifugation the supernatant 
was freeze-dried and the dry material was weighed. The yield in crude extract was about 
18%. All doses used in the experiments were based on this estimation. For each 
experiment, a sample of the freeze-dried extract was dissolved in 0.9% NaCl and then 
centrifuged at 3000 x g for 10 min and stored at +4°C. 
Animals 
For all experiments, mature Wistar rats were purchased from IFFA-CREDO, France, and 
maintained on a 12 h light-dark cycle (lights on from 6.00 - 18.00 h). They were housed 
individually in standard plastic cages with wood chips on the floor and were given food 
and water ad libitum. 
Experimental protocols 
7. Effect of oral treatment with AN extract on milk production 
Experiment A 
Eighteen lactating dams, weighing 225-250 g at the beginning of lactation and suckling 8 
to 9 pups, were used in this experiment. Females were divided into three experimental 
groups and received either 2 ml of 0.9% NaCl (n=6) or 280 mg (n=6) or 560 mg AN-
extract / kg BW / 2 ml 0.9% NaCl (n=6), respectively. 
Experiment B 
Fifteen lactating dams, weighing 225-250 g at the beginning of lactation and suckling 8 to 
9 pups, were divided into two experimental groups and received either 2 ml 0.9% NaCl 
(n=7) or 280 mg AN-extract / kg BW/ 2 ml 0.9% NaCl (n=8), respectively. 
All animals were treated daily, starting on the evening of day two of lactation. The extract 
was administered orally with a gavage syringe each day at 18:00 h. Milk production was 
estimated 18 h (for experiment A) and 23 h (for experiment B) after gavage. 
In both experiments, milk production was measured from day 3 to day 15 of lactation. 
Milk yield and body weight of dams, and weight gain of pups were measured each day. 
Every day during the study period (experiment A) the pups were weighed at 7:00 h (wl) 
and subsequently isolated from their mother for 4 hours (Sampson & Jansen 1984). At 
11:00 h the pups were weighed (w2), returned to their mother and allowed to feed for 1 
hour. At 12:00 h, they were weighed (w3). In experiment B, the same procedure was 
followed, but the pups were isolated between 12:00 h and 16:00 h. After weighing at 16:00 
h (w4), they were reunited with their mother for 1 hour of feeding and, finally, they were 
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weighed (w5). They were then left with their mother during the night. For weight 
measurements, an electronic balance (Sartorius Basic plus) accurate up to 0.01 g was used. 
Milk yield was estimated as w3-w2 (milk yield 18 h after the gavage) and w5-w4 (milk 
yield 23 h after the gavage). Daily milk yield was corrected for weight loss due to 
metabolic processes in the pup (respiration, urination, and defecation) during suckling. 
The value used was (w2-wl) / 4 or [(w2-wl) + (w4-w3)] / 8 for the first and the second 
group of animals, respectively. This value was then multiplied by the number of suckling 
hours per day and added to the daily suckling gain (Sampson & Jansen, 1984). Daily 
weight gain of pups was calculated from the pup weight at w2. 
//. Effect of intravenous (Lv.) injection of AN extract on plasma and pituitary PRL 
concentration 
Eighteen cycling virgin rats aged 90 days and weighing 200-250 g were cannulated in the 
jugular vein by the method described by Van Dongen (1990). A week after cannulation, 
the animals were divided into 3 groups and received either 0.2 ml 0.9% NaCl or 45 mg or 
110 mg AN- extract / kg BW / 0.2 ml 0.9% NaCl. All doses were given as a single 
injection each day via the intravenous cannula during a period of six days. 
Animals were adjusted to blood sampling procedures two days before the start of the 
experiment. On day 1 (at diestrous) and day 3 (at estrous) of the treatment, two plasma 
samples were taken before and five samples after the injection, at 20 min intervals. The 
blood samples were centrifuged and plasma was stored at -20°C until radioimmunoassay 
(RIA) for PRL content. On the 7' day of the experiment, the animals were sacrificed by 
decapitation under ether anesthesia. Pituitaries were collected for PRL extraction. 
Extraction occurred in a Potter tube at 0°C with PBS pH 7.4, 0.03 M; 10 ul of the 
homogenate was diluted with phosphate buffer plus 1% BSA and stored at -20°C. 
Plasma and pituitary PRL levels were measured using rat reagents distributed by the 
NIDDK (NIH, Bethesda, MD). PRL values were expressed in terms of the reference 
standard RP-3. The intra-assay variation was 7.92% and 9.95% for plasma PRL and 
pituitary PRL, respectively. 
///. Effect of intramuscular injection of AN extract on mammary gland tissue 
The animals used in this experiment were first-generation descendants of the rats 
purchased from IFFA-CREDO. Thirty-six virgin female rats aged 60-70 days were 
divided into 2 groups. The first group first received a subcutaneous injection of estradiol in 
a dose of 10 \ig I 0.1ml sesame oil twice daily for 2 days. Subsequently they were divided 
into 3 subgroups and received an intramuscular injection (i.m.) of either 0.9% NaCl or 200 
mg or 400 mg AN-extract/kg BW twice daily for 5 days. The second group first received 
an injection of 0.9% NaCl and was then divided into 3 subgroups receiving the same 
injections as the first group. On the 6th day, all animals were anaesthetized with ether and 
sacrificed by decapitation. Pituitaries were collected for PRL extraction, as previously 
described. The two inguinal mammary glands were removed, immediately fixed in 
alcoholic Bouin and embedded in paraffin after dehydration in a graded series of ethanol 
and xylene. Paraffin sections (5 //m) of the mammary glands were sliced and stained with 
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Harris' hematoxilin and eosin. Mammary gland structures were identified according to the 
criteria of Russo and Russo (1978, 1996) and Masso-Welch et al. (2000) using a Zeiss 
microscope coupled to an image analysis system. 
IV. Effect of the treatment with AN extract after bromocriptine injection 
Twenty-four female rats of 90 days were divided into 4 groups. Two groups were treated 
orally with 2 ml NaCl 0.9% (n=6) or 550 mg AN-extract/kg BW/2 ml NaCl 0.9% (n=6) 
twice daily during 5 days, respectively. The remaining two groups were treated 
subcutaneously with bromocriptine (CB154) at the dose of 4.5 mg/kg BW/0.25ml ethanol 
70% twice daily during 2 days. Then they were treated orally by gavage with 2 ml NaCl 
0.9% (n=6) or 550 mg AN-extract /kg BW/2 ml NaCl 0.9% (n=6) twice daily during 3 
days. The 6th day, all animals were anaesthetized with ether and sacrificed by decapitation. 
Pituitaries were collected for PRL extraction and determined as described above. 
Statistical Analysis 
Data were analyzed by Student's t-test or one-way ANOVA, followed by either the 
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Figure 1 Effect of aqueous extract of AN on milk production 
C (•) control group treated with 0.9% NaCl (n = 6); T280 mg ( ^ ) group receiving 280 mg AN-extract / kg BW (n 
= 6); T560 mg (O) group receiving 560 mg AN-extract / kgBW (n = 6). Values are the means ± SEM. Statistically 
significant difference is observed during the whole period for the group receiving 560 mg (PO.01). A significant 
difference is observed between days 8-11 and days 14-15 for the group receiving 280 mg (PO.05). Statistically 




Milk production of both groups receiving 280 mg and 560 mg AN-extract was higher 
compared to that of the control group, as illustrated in Figure 1 (experiment I-A). Milk 
yield increased from 1.38 ± 0.16, 1.44 ± 0.15, and 1.52 ± 0.05 g / pup / day to about 3.07 ± 
0.29, 4.46 ± 0.06, and 5.27 ± 0.15 g / pup / day for the controls, and those receiving 280 
and 560 mg, respectively. The differences observed were significant from day 2 until the 
end of treatment, in particular for the 560 mg dose group (ANOVA followed by 
Bonferroni, PO.01). The mean milk yield was 2.12 ± 0.17, 2.83 ± 0.23 and 3.36 ± 0.32 g / 
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Figure 2 Mean milk production per day. Values are the means ± SEM. Statistically significant differences observed: 
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Figure 3. Mean milk production 18 h and 23 h after gavage. Values are the means ± SEM and have been given per 5 h (4 
h separation + 1 h suckling). 
Milk yield 18 h or 23 h after gavage with either saline (C18 h, C23 h, n = 7) or 280 mg AN-extract (T18 h, T23 h, n = 8). 
The Scheffe test is used to assess differences between groups, P<0.05. 
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correction at least PO.05) (Figure 2). 
Milk production data 18 h and 23 h (experiments I-A and B, respectively) after gavage 
indicated that milk production was significantly increased in all groups receiving the 
extract at both time points (ANOVA followed by Scheffe P<0.05) (Figure 3). The mean 
milk yield of the control group was 0.37 ± 0.02 and 0.38 ± 0.03 g / pup / 5 h 18 h and 23 h 
after gavage with saline, respectively. For the group receiving extract, mean milk yield 
was 0.51 ± 0.02 and 0.57 ± 0.03 g / pup / 5 h 18 h and 23 h after treatment, respectively. 
Body weight 
All pups gained weight during the study period (Figure 4) and the rate of weight gain for 
the treated groups was significantly higher than that for the controls. Body weight 
increased from 7.83 ± 0.39 to 17.65 ± 1.54 g / pup for the controls, from 8.17 ± 0.66 to 
22.94 ± 0.57 g / pup for those receiving 280 mg and from 8.72 ± 0.39 to 25.20 ± 1.51 g / 
pup for those receiving 560 mg AN-extract. The daily weight gain was 0.86 ± 0.08, 1.42 ± 
0.12 and 1.43 ± 0.11 g / pup, respectively (Figure 5). A significant difference was 
observed between all treated groups and the controls (Student's t-test with Bonferroni 
correction PO.01). No significant effect on body weights of dams was seen. 
PRL content 
To evaluate the effects of extract on PRL secretion and release, PRL concentrations were 
measured in both plasma and pituitary. In experiment II, the effect of i.v. administration of 
the extract on the plasma PRL concentration was studied; see Figure 6. A wide variation in 
individual responses to treatment was observed. However, plasma PRL concentrations 









Day of lactation 
Figure 4 Effect of aqueous extract of AN on pup weight. Values are the means ± SEM. A significant difference was 
observed between the treated group and the controls (at least PO.05). C (•) T280 mg (J^) T560 mg (O ). Same treatment 
as in Figure 1. 
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levels remained constant (ANOVA followed by Bonferroni, at least P<0.05). On day 1 
("acute treatment") of treatment, the highest levels were observed 60 min after injection. 
They remained relatively high until day 3 of treatment where the highest levels were 
observed earlier (40 min). PRL levels 40 min after injection were 1.23 ± 0.35, 2.95 ± 1.46 
and 56.03 ± 22.84 ng / ml for controls, and the groups receiving 45 and 110 mg on day 1 
of the treatment, respectively. On day 3 ("chronic treatment"), the plasma levels were, at 
the same times, 4.02 ± 0.76, 10.53 ± 2.44 and 43.93 ± 16.24 ng / ml for controls, and the 
group receiving 45 and 110 mg, respectively. Furthermore the pituitary PRL content for 
the same animals (Figure 7) was significantly increased in the group receiving 110 mg 
compared to the controls (ANOVA followed by Bonferroni, P< 0.01) although no 
significant increase was found for the group receiving the lower dose. 
Regarding pituitary PRL in animals receiving the extract i.m.(Experiment III), 
significantly higher PRL concentrations were observed in the E2-primed animals treated 
with the extract, as compared to non-primed ones (ANOVA, follow by Bonferroni, at least 
P<0.05) (Figure 8). Moreover, a significant increase was found for E2-primed animals 
receiving extract compared to the E2-primed control group. In both CB154 treated groups 
(Figure 9), pituitary PRL content was significantly lower compared to control value 
(ANOVA, follow by LSD P<0.05). AN treatment significantly increased PRL content 
compared to both that in animals treated with CB154 alone or with CB154 + AN-extract 











Figure 5 Mean weight gain of the pups. Values are the means ± SEM. ** Statistically significant (PO.01) (Student's t-test 
followed by Bonferroni correction). C, T280 mg, and T560 mg. Same treatment as in Figure 1. 
56 
Histology of mammary tissue 
To understand the relationship between PRL and mammary growth, the histology of rat 
mammary gland tissues was studied in the third experiment (Figure 9). The mammary 
glands ofnon-E2-primed rats treated with saline show a bare duct system and terminal end 
buds (TEBs) within an important fat pad (A). Although the mammary gland of the E2-
90 
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Fig. 6 Plasma PRL profiles (i.v. injection) on day 1 (acute effect) and day 3 (chronic effect). Values are 
the mean ± SEM. 'statistically significant compared to both controls and the group receiving 45 mg (at 
least P<0.05), # Statistically significant compared to the controls (at least P<0.05) (ANOVA followed by 
Bonferroni). C (•) control treated with 0.9% NaCl (IV), T45 mg ( J ) group receiving 45 mg of plant 
extract / kg BW (IV), and Tl 10 mg (;g) group receiving 110 mg of plant extract / kg BW (IV). "0" time 
represents the time of injection of AN extract with samples taken at 20-minute intervals post-injection. 
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primed animals consisted of ducts branching into ductules (B), no alveolar development 
was observed. In all E2-primed and non-primed animals receiving the extract (C-F), 
ductule branching with alveolar development was observed, as well as lipid droplets in the 
alveoli. However, there was no evidence of secretion into ducts of the non-primed group 
receiving 400 mg plant extract / kg BW (E). The largest alveolar structures with basophilic 
secretions in the lumen of alveoli and ducts were observed in the estrogen-primed group 
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Figure 7 Pituitary PRL content after i.v. injection treatment during six days. Values are the means ± SE. ** 
Statistically significant (PO.01) (ANOVA followed by Bonferroni). C: control group receiving 0.9% NaCl 
(IV, 6 days); T 45 mg: group receiving 45 mg of plant extract / kg BW (IV, 6 days); Tl 10 mg: group receiving 














Figure 8 Pituitary PRL content after intramuscular injection. Values are the mean ±SEM. * Statistically significant 
compared to the control, # Statistically significant compared to the E2-primed control group (ANOVA followed by 
Bonferroni, at least P<0.05). Without E2: not previously treated with estradiol. With E2: previously treated with 
estradiol. C: control group receiving 0.9% NaCl (IM, 5 days), T200 mg: group receiving 200 mg of plant extract / kg 
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Figure 9 Pituitary PRL content after oral administration of extract and after subcutaneous injection of CB154. Values are 
the mean ± SEM. * Statistically significant compared to the bromocriptine treated group receiving the extract. (ANOVA 
followed by LSD, P<0.05). C: control group receiving 0.9% NaCl (oral, 5 days). CB: group receiving CB154 injection 
(subcutaneous, 5 days). CB+T550 mg: group receiving CB154 injection (subcutaneous, 2 days) + T550 mg (oral, 3 days). 
T550 mg: group receiving the extract (oral, 5 days). 
Discussion 
The measurement of milk production in the rat model is difficult. Milk yield estimations 
for rats by means of pup weight and weight gains have been used in several studies 
(Morag et al. 1975, Sampson & Jansen 1984, Kamani et al. 1987, Kim et al. 1998). It has 
to be noted that the purpose of this study was essentially to determine whether AN is 
lactogenic. As expected, milk production was significantly higher in treated animals than 
in controls. In addition, milk yield appears to be significantly stimulated about 24 h after 
administration of the extract and pup growth rate was significantly improved. Moreover, 
pup growth rate in the group receiving the low dose (i.e. in the same range as that used by 
native women) was similar to that in the group receiving the high dose, whereas the dams 
produced 20% less milk. This suggests a possible effect of the extract on milk 
components. However, this suggestion can only be confirmed by studying the composition 
of the milk. Likewise, extract of Asparagus racemosus has been observed to stimulate 
milk production in buffaloes (Patel and Kanitkar 1969). On the other hand, treatment with 
some of these plants did not improve rat pup growth (Kamani et al. 1987) and milk 
production in ewes (Sawadogo et al. 1989), but it did stimulate PRL secretion in ewes 
(Sawadogo et al. 1989). Interestingly, the results obtained in this study show that not only 
milk production was increased, but plasma and pituitary PRL levels as well. The 
mechanism of action is still unknown as well as the active components of the extract. 
However, we suggest an effect through the hypothalamo-pituitary axis leading to the 
synthesis and release of PRL, as observed in previous studies (Sawadogo et al. 1987, 
1989, Sepehri et al. 1990, 1992). Moreover, the pituitary PRL content in peri-pubertal 
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Figure 10 Sections of mammary glands from virgin estrogen (E2)-primed and non-primed rats, 60 to 70 days old 
treated with saline or plant extract. 
A: Section of mammary gland from a non-primed rat receiving 0.9% NaCl showing ductules and TEBs, with no 
alveolar development. B: Mammary gland from an E2-primed rat receiving 0.9% NaCl showing ducts branching into 
ductule, with fewer alveolar buds (Alv). C: Mammary gland from a non-primed rat receiving 200 mg of plant extract / 
kg BW, showing duct branching to ductule with modest alveolar structure development. D: Mammary gland from an 
E2-primed rat receiving 200 mg of plant extract / kg BW, showing ductule branching with alveolar development, 
adjacent blood vessels (BV) and lymphatic tissue (ly). E: Mammary gland from a non-primed rat receiving 400 mg of 
plant extract / kg BW showing a welldefined alveolar structure with lipid droplets within the alveoli. F: Mammary 
gland from an E2-primed rat receiving 400 mg of plant extract / kg BW showing a well-defined alveolar structure 
with lumens filled with basophilic secretions (S). Paraffin sections of 5 urn were stained with Harris hematoxilin and 
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animals treated with the extract did not significantly differ from the control as compared to 
that in cycling females treated intravenously with extract. This indicates that the extract 
exerts a specific PRL-secretion activity under certain physiological conditions. A strong 
relation between treatment with extract and PRL release after "acute" as well as "chronic" 
treatment has been observed. From this, it can be expected that the underlying mechanism 
of PRL elevation will be related to neuro-endocrine regulation. Our results suggest 
involvement of dopaminergic activity, since treatment with extract after CB154 injections 
did not increase pituitary PRL content. 
Obviously, PRL is known to stimulate milk synthesis and secretion, but in the last 
decades, research has also shown a relationship with breast carcinogenesis; the increase in 
PRL synthesis and release may increase susceptibility to carcinoma (Venugopal et al. 
1999). In this study, extract of AN was shown to stimulate mammary gland development 
and the differentiation of the lobulo-alveolar system from the lobular buds with milk 
secretion within the lumen. Immunohistochemical data on mammary cell proliferation 
must be obtained before any statement on the carcinogenic effect of the plant can be made. 
However, women have used this plant for generations without any pathologic effects being 
reported. Further investigations are in progress and will provide increased understanding 
of the effect of the extract on mammary gland development. 
In conclusion, it can be stated that aqueous extract of AN effectively stimulates milk 
production as well as PRL synthesis and release in the rat. Therefore, the traditional belief 
that AN extract can improve milk production in lactating women may be valid. 
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Abstract 
Past research shows that Acacia nilotica ssp. adansonii (AN) extract can stimulate milk 
production and prolactin (PRL) synthesis and release in rats. As milk yield and persistency 
of lactation are related to mammary gland growth and differentiation, the major objective 
of this study was to investigate the in vivo response of mammary epithelium to AN-
extract. To this end, peripubertal virgin female rats were treated with AN extract, either 
oral or i.m., in the presence or absence of exogenous estradiol (E2). Rats treated with 
perphenazine or sulpiride, two selective dopamine receptor antagonists, were included as 
positive controls. One hour before sacrifice, BrdU was administered subcutaneously and 
mammary gland tissue was collected and processed for BrdU immunocytochemical 
staining. 
The treatment with extract resulted in significantly more lobulo-alveolar structures filled 
with basophilic secretions and lipid globules compared to controls (P<0.05). Terminal end 
buds (TEBs) were completely absent in the E2-primed, high dose AN-treated groups when 
treatment was given intramuscularly. In contrast, AN-extract did not affect TEBs 
formation in the absence of E2. The overall mammary response to AN-extract was 
potentiated by the concomitant presence of E2, albeit that limited alveolar differentiation 
was observed in the AN-treated animals compared to the perphenazine or sulpiride treated 
groups. The BrdU labelling index was significantly increased following oral 
administration of AN extract compared to control. In both perphenazine and sulpiride-
treated animals, the BrdU labelling index was significantly lower than that of AN treated 
animals. 
This study shows that mammary cell proliferation was significantly higher in AN-treated 
groups compared to control, and that the more the lobular unit is differentiated, the less 
cell proliferation is present, as measured by the decrease in BrdU labelling index. We 
conclude that AN-extract is able to stimulate mammary gland growth and differentiation 
from the least differentiated structures (TEBs) to the fully developed mammary gland 
showing active milk production. 
Introduction 
The mammary gland of rats is composed of multiple cell types and can be divided roughly 
into two compartments (Masso-Welch et al. 2000). The epithelial compartment is 
composed of different epithelial structures with distinct morphology, and functional and 
proliferative activity (i.e. epithelium of ducts, ductules, terminal end buds (TEBs), alveolar 
buds, alveoli, and myoepithelial cells). The stromal compartment, which is distinct in 
thickness, composition, and density, surrounds ducts, ductules, and alveolar lobules and 
contains many fibroblasts and adipocytes. 
It is well known that development and differentiation of mammary gland structures are 
hormone dependent processes and that blood levels of those hormones vary during the 
reproductive cycle. The regulation of mammary gland activity is dominated by the 
inhibitory hypothalamic dopamine (DA) mechanism that directs pituitary prolactin release 
(PRL). Administration of perphenazine or sulpiride, a selective D2 and Dl receptor 
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antagonist, respectively, to female rats resulted in an increase in PRL secretion and 
release, thus stimulating lactation. The perphenazine-induced PRL elevation is associated 
with a growth response of the mammary gland and a large proliferative response that 
occurs in the working unit of the gland, the lobule (Stringer et al. 1990). 
During early development, rising levels of endogenous estradiol (E2) promote mammary 
duct branching that ends in highly proliferative structures termed TEBs. TEBs are the 
major sites of proliferation (Monaghan et al. 1990) leading to the formation of lobular 
units (Howard and Gusterson 2000) with the advancement of puberty. The main 
characteristic of a mature mammary gland is the absence of TEBs and the presence of a 
highly branched architecture terminated by lobular buds (Horseman 1999). During 
pregnancy, the lobular buds give rise to alveolar lobules, which increase both in size and 
number and reach maximal development at the end of pregnancy (Masso-Welch et al. 
2000). At the end of pregnancy, the mammary gland has reached a high rate of 
proliferation and the epithelium has achieved a profound biochemical transformation that 
leads to the synthesis of specific components of milk such as proteins (casein), lipids (fatty 
acids), and sugar (lactose). During this period, the myoepithelial cell layer, which 
surrounds the alveolar epithelium, has acquired abundant cytoplasmic filaments for 
contractile functions during lactation (Joshi et al. 1986). Mammary cell proliferation 
continues throughout lactation with a peak on day 3 in rats (Joshi et al. 1986). The lobulo-
alveolar epithelium is subsequently transformed into a secretory epithelium, which 
synthesises milk components and lactogenic enzymes. Although the great variability of 
hormones in maternal plasma is required for lactogenesis, a fully differentiated mammary 
gland is the primary determinant for sufficient milk yield and persistency of lactation (Kim 
et al. 1998). During lactation, prolactin regulates the synthesis of milk in the mammary 
gland. Previous reports show that extract of Acacia nilotica (AN) can increase milk 
production and PRL secretion and release (Lompo et al. submitted) and can induce j8-
casein accumulation in mammary glands of rats (Sawadogo 1988a). In this study, we 
investigated the effect of AN extract on mammary cell proliferation using 
bromodeoxyuridin (BrdU). BrdU is an analogue of thymidin that is incorporated into the 
DNA of proliferating cells. To this end, different doses of AN-extract were compared with 
control treatment in peripubertal virgin female rats pretreated with either E2 or NaCl. 
Histological evaluation of mammary gland development as well as quantification of 
selective BrdU incorporation into specific mammary gland structures was performed. 
Materials and Methods 
Animals 
Wistar virgin female rats were obtained from IFFA-CREDO, France. They were kept 
under controlled light-dark cycles (lights on from 6:00 h to 18:00 h) at 22-28° C and had 
free access to pelleted food and tap water. Females were weighed every day. The animals 





Forty-two virgin female rats, aged 60-70 days, were divided into 2 groups. The first group 
(n=18) first received a subcutaneous injection of E2 in a dose of 10 (J.g/0.1 ml sesame oil 
twice daily for 2 consecutive days. Subsequently, they were divided into 3 subgroups of 6 
animals each receiving an i.m. injection of saline, 200 mg or 400 mg-AN extract/kg BW 
once daily for 5 consecutive days. 
The 2nd group of animals (n=24) served as controls for the estrogen pretreatment and 
received an injection of 0.1 ml of 0.9% NaCl twice daily for 2 consecutive days. They 
were subsequently divided into 4 groups of 6 animals receiving either saline, 400 mg-AN 
extract/kg BW, 20 mg perphenazine/kg BW or 20 mg sulpiride/kg BW once daily for 5 
consecutive days. AN extract and saline were administered intramuscularly; perphenazine 
and sulpiride were given subcutaneously (s.c). 
Experiment 2 
Thirty virgin females, aged 60-70 days, were divided into 5 groups of 6 animals each. 
Four groups first received a subcutaneous injection of E2 in a dose of 10 ng/0.1 ml sesame 
oil twice daily for 2 consecutive days and were subsequently treated orally with either 
saline or 1 g or 2 g or 3 g AN extract/kg BW once daily for 5 consecutive days. The 
remaining group first received 0.1 ml saline twice daily for 2 consecutive days and was 
then treated orally with 3 g AN extract/kg BW once daily for 5 consecutive days. 
On day six for both experiment 1 and 2, females were injected i.p. with 5 mg BrdU/kg BW 
and 2 hours later sacrificed by decapitation under ether anaesthesia. The inguinal 
mammary glands were removed and subsequently frozen for immunocytochemical 
staining. Pituitaries were collected for PRL extraction as described previously (Lompo et 
al. submitted). Pituitary PRL was measured using rat reagent kindly provided by the 
NIDDK (NIH, Bethesda, MD). PRL values were expressed in terms of the reference 
standards RP-3. The intra-assay variation was determined using pooled rat serum and 
amounted to 7.92% and 9.95% for plasma and pituitary PRL levels, respectively. 
Immunohistochemistry 
Frozen sections 
Unfixed rat mammary glands collected as described above were used for 
immunocytochemical staining. Eighteen cryostat sections (10 um) taken at regular 
intervals (every 50 um) were randomly cut from each frozen mammary gland. The 
sections were mounted on Superfrost Plus slides coated with 0.1% poly-1-lysine and 
collected in boxes containing desiccant, wrapped with parafilm, and stored at -20° C until 
use. 
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Unfixed frozen sections of the rat intestine treated or not with BrdU, and rat mammary 
glands not treated with BrdU were used as positive and negative controls of the BrdU 
staining. 
Staining procedure 
The immunocytochemical (ICC) staining was performed according to McGinley et al. 
2000 with some modifications. 
Briefly, the sections were allowed to return to room temperature before unwrapping, after 
which they were fixed in Carnoy's solution for 10 min, followed by methanol for 5 min 
and subsequently hydrated in distilled water for 30 min. 
The sections were then immersed in 2N HC1 for 90 min to hydrolyse the DNA. 
Subsequently, sections were rinsed several times (4 times 10 min) in distilled water and 
acid hydrolysis was stopped by immersion in 0.1 M sodium borate for 5 min followed by 3 
rinses with distilled water (3 times 10 min). Endogenous peroxidase activity was blocked 
by immersing sections in 3% H2O2 for 5 min. Sections were rinsed in distilled water (3 
times 10 min), followed by TBS pH 7.4 (3 times 5 min). All subsequent steps were 
performed in a humidity chamber. Primary antibody (mouse anti-BrdU final dilution 1:750 
diluted in TBS, pH 7.4) was applied to the sections except for slides used for method 
control that were incubated with the same amount of TBS. The incubation in primary 
antiserum was performed at room temperature overnight (17 hrs). The secondary antibody, 
biotinylated horse anti-mouse IgG, rat preabsorbed (Vector Laboratories, Burlingame, 
final dilution 1:250 in 10% normal horse serum diluted in TBS) was applied to all sections 
and incubated for 60 min. Thereafter, sections were incubated with horseradish 
peroxidase-conjugated streptavidin (Vector Lab., final dilution 1:750) for 90 min and 
thoroughly washed in TBS (3 times 5 min). Subsequently, 3,3'-diaminobenzidine (DAB, 
with 0.03% H2O2 added to it) was used for 15 min to visualize the staining. Finally, after 
rinsing in TBS (3 times 10 min), sections were counterstained in diluted Harris 
haematoxylin (1:10) for 5 min, rinsed in distilled water (3 times 10 min) followed by tap 
water (3 times 5 min). Sections were dehydrated in a series of graded ethanol, cleared in 
xylene and cover slipped using DEPEX®. 
Counting of BrdU positive cells 
To assess BrdU incorporation, a computer-assisted counting procedure was used. BrdU 
positive cells were analysed using a Zeiss microscope with a CCD-camera, coupled to a 
SCION image analysis system. All images were captured at a magnification of lOOx (or 
200x) and collected for analysis, using Scion image. Before capturing an image, the 
camera was calibrated for area measurements (nm). For counting a random sampling of 
microscopic fields was used, which reduced the likelihood of field sampling bias in 
specimen analysis. Each slide contained 6 sections of mammary gland. For each section, 
the slide was moved to a position at which the higher left corner of the section was in the 
field of view and 3 images were randomly captured from the left corner to the right corner. 
Then, the slide was moved to a position at which the lower left corner of the section was in 
the field of view. Again, 3 images were randomly captured from the left to the right. Thus, 
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for each section, six images were taken and saved in which the X and Y coordinate values 
were automatically displayed thanks to the initial calibration. The number of BrdU 
positive nuclei counted in each image was expressed as the percentage of the total number 
of cells in the average of all images in the same treatment group. 
Counting of mammary gland structures 
For the determination of the degree of mammary gland differentiation, the number of 
structures was counted as previously described using the morphological criteria of Russo 
and Russo (1978, 1996). Histological analysis was routinely performed on the inguinal 
mammary tissue to minimise differences in mammary gland morphology. The number of 
structures was expressed per unit of area (mm2). Mammary gland composed of only ducts 
and TEBs was scored as 0. Mammary gland with small lobules composed of 5 or fewer 
acini were scored as 1, those with 6-10 acini as 2, those with 11-20 acini as 3 and those 
with more than 20 were scored as 4. Mammary glands with lobules composed of very 
large acini were scored as 5. 
Statistical analysis 
Data were expressed as mean percentage BrdU+/cell total/mm2. Statistical evaluation of 
PRL data was performed using ANOVA followed by a post-hoc Bonferroni and Scheffe 
test to identify differences between groups. PO.05 was considered significant. 
Results 
Mammary gland differentiation 
A total of fifty-four to seventy-two randomly collected mammary gland fields in each 
animal were used to analyse the effects of AN extract on inguinal mammary gland 
development. This method of quantification has the advantage of including ducts, alveoli 
or alveolar buds and TEBs in approximately the same proportion as they occur in the 
whole gland. Mammary glands of control animals pretreated with saline only showed 
ducts and TEB structures and very few alveoli (Figure 1A), while mammary gland of E2-
primed animals clearly exhibit more TEBs and more alveolar structures (Figure IB). 
Perphenazine and sulpiride treatment resulted in large alveolar structures with milk 
secretion in the lumen (Figure 2). The amount of stromal tissue was clearly decreased 
compared to control or E2-primed animals (see Figures 1 and 2). The number of 
differentiated alveolar structures (lobules type II) was higher in the perphenazine 
compared to the sulpiride treated animals. In all animals treated with AN-extract, ductules 
branching to lobule type I and II were present (Figure 3). Figures 3A and 3B show 
mammary gland from a rat treated intramuscularly with 200 mg AN extract /kg BW, and a 
rat treated with 400 mg AN-extract/kg BW after priming with E2 respectively. The size of 
the mammary gland structures was clearly increased following a higher dose of AN 
extract. Figures 3C and 3D show typical mammary glands from rats receiving NaCl + 3 g 
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Figure 1: Photographs showing mammary gland development and differentiation in control (NaCl) (panel A, C and E) 
and E2-primed animals (panels B, D and F). Panels A and B show mammary gland following haematoxylin-eosin 
staining at low magnification. Extension of the ducts (Dc) into alveolar buds (Alvbds) can be clearly seen following E2-
treatment. Note the abundance of adipose tissue surrounding the structures. Panels C-F show mammary gland following 
BrdU immunocytochemical staining at low (panels C, D) and high (panel E, F) magnification. Note the increase in size 
of the terminal end bud following E2-treatment (panels D, F). Arrows point to BrdU positive cells within the mammary 
structure. Adp: adipose tissue; Teb: terminal end bud; Pt: stromal tissue. Magnification panels A and B (lOOx), panels C 
and D (200x) and panels E and F (400x). 
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or E2 + 3 g AN extract/kg BW, respectively. Oral treatment also resulted in a clear 
differentiation of mammary gland structures in E2-primed as well as control (NaCl) 
animals. More stromal tissue was seen surrounding the lobules in AN-treated glands than 
in the glands from perphenazine or sulpiride treated animals. 
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Figure 2 Photographs showing mammary gland development and differentiation following sulpiride (panels A, C) or 
perphenazine (panels B, D) treatment. Panels A and B show mammary gland following BrdU staining at low 
magnification (lOOx). The amount of alveolar structures lobule type II was clearly increased after perphenazine 
treatment. Note the decrease in the amount of stromal tissue compared to that in control animals in Figure 1. Panels C 
and D show mammary gland following BrdU immunocytochemical staining at higher magnification (400x). Arrows 
point to BrdU positive cells. Alv: alveoli; S: milk secretion in lumen. 
Quantification of mammary gland structures revealed that animals that received saline 
treatment, alone or in combination with E2 had significantly more TEBs than those glands 
from AN-treated animals where more lobules were observed (Table 1). Intramuscular AN-
treatment appeared to stimulate lobulo-alveolar development from TEBs as evidenced by 
the lower number of TEBs compared to control treatment in the low dose and the complete 
absence of TEBs in the estrogen-primed high dose AN-treated group. Mammary gland 
tissue from perphenazine and sulpiride treated animals showed consistently less ducts 
compared to all other treatment groups and no TEBs were observed. Also, perphenazine 
treated animals showed a higher degree of structural differentiation compared to sulpiride 
treated rats, as evidenced by the increase in lobule type II and the absence of lobules type I 
in perphenazine treated animals. End buds were still clearly present in the mammary gland 
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of animals treated orally with a low dose of AN-extract, albeit that the number decreased 
following the higher dose of AN extract. Oral AN-treatment resulted in a higher degree of 
differentiation of the mammary gland compared to E2 alone, lobules type II were only 
present in AN-treated animals. Lobules type I and II were also present in control, NaCl 
animals that were treated orally with the high dose of AN extract. No clear differences 
were seen between the number of ductal structures of all treated and untreated animals, 
except following the pharmacological intervention, where a decrease was demonstrated 
(see Tables 1 and 2). 
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Figure 3 Photographs showing BrdU immunocytochemical staining of mammary gland development and differentiation 
after 200 mg i.m. (panel A), 400 mg (panel B) or oral treatment (panel C) with AN extract in sodium chloride (control) 
primed animals. Panel D shows an example of mammary gland from a E;-primed animal following 3 g AN extract 
orally. Arrows point to a distinct lobule type II within the alveolar structure, arrowheads point to BrdU positive cells. 
Magnification 400x. 
Mammary cell proliferation 
Using BrdU incorporation and immunocytochemical detection, mammary cell 
proliferation was analysed in ducts and lobules. A low number of BrdU positive cells were 
clearly visible in the TEBs of control, NaCl as well as E2-primed animals (Figures 1C-F). 
BrdU positive cells were occasionally present in the differentiated lobule type I and II 
structures frequently found in the perphenazine and sulpiride treated animals (Figures 2C-
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increased compared to that seen in control animals with or without E2-priming (see 
Figures 1 and 3). As seen in Tables 3 and 4, the labelling index was significantly higher in 
both lobules and ducts in all AN-treated animals compared to that observed in controls. 
The labelling index in the ductal structures for i.m. treated animals increased from 8% in 
both NaCl and E2 + NaCl-treated animals to 15% and 13% in E2 + 200 mg and E2 + 400 
mg-treated animals, respectively. 
Table 1 Number of mammary gland structures in control and E -primed animals after i.m. treatment with AN extract or 
after sulpiride or perphenazine treatment, expressed as number of structures / mm2 area (mean ± SEM), A: absent. 
D TEB U L2 
NaCl 2.30 ±0.15 2.09 ±0.17 
E2 + NaCl 2.74 ± 0.22 2.70 ± 0.02 
E2 + 200 mg 2.31 ± 0.06 1.28 ± 0.05 
E2 + 400mg 2.39 ±0.11 A 
Sulpiride 0.74 ± 0.05 A 
Perphenazine 1.40 ±0.05 A 
In the lobules, the labelling index increased from 9% in E2 + NaCl-treated animals to 20% 
and 25% in E2 + 200 mg and E2 + 400 mg, respectively. Moreover, the labelling index in 
lobules type I and II appeared to be dose-dependent, i.e. a dose of E2 + 400 mg 
consistently showed a higher labelling index compared to E2 + 200 mg AN extract. In the 
ductal structures, the labelling index was much higher in the oral AN-treated animals 
(Table 4) compared to that in the i.m.-AN groups (see Table 3). 
Table 2: Number of mammary gland structures in control and E2-primed animals after oral treatment with AN extract 
expressed as number of structures / mm2 area (mean ± SEM), A: absent. 
5 TEB LI L2 
NaCl 2.22 ± 0.08 2.09 ±0.15 A A 
E2 + NaCl 2.74 ±0.22 2.70 ±0.02 2.3 ±0.07 A 
E 2 + l g 2.77 ±0.15 2.92 ±0.09 3.63 ±0.33 2.60±0.12 
E2 + 2g 2.62 ±0.12 1.78 ±0.08 3.27 ±0.25 4.12 ±0.26 
E2 + 3g 3.26 ±0.28 0.54 ±0.10 4.63 ±0.22 3.70 ±0.13 
NaCl + 3g 2.30 ±0.13 1.41 ±0.07 2.97 ±0.42 3.39 ±0.18 
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The labelling index in the orally treated animals, however, decreased from 23% to 20% in 
lobules type I, and from 28% to 17% in lobules type II, for E2 + 1 g AN extract/kg BW 
and E2 + 3 g AN extract/kg BW, respectively. All animals treated with either sulpiride or 
perphenazine showed a significantly lower labelling index compared to that in the other 
groups. The differentiation of the mammary structures was clearly influenced by the AN 
treatment as demonstrated by the changes in both number of alveoli as well as number of 
cells counted in each alveoli (Table 5). Also, perphenazine treatment resulted in a higher 
number of alveoli, and cells per alveoli, compared to sulpiride treatment. 
Table 3: Labelling index in control and E2-primed animals after i.m. treatment with AN extract or following sulpiride or 
perphenazine treatment expressed as percentage BrdU positive cells / total cells within a structure (mean ± SEM), A: 
absent. 
NaCl 
E2 + NaCl 
E2 + 200 mg 






















0.62 ± 0.03 
2.21 ±0.27 
Table 4 Labelling index in control and E2-primed animals after oral treatment with AN extract expressed as the 
percentage BrdU positive cell/ total cell within a structure (mean ± SEM), A: absent. 
NaCl 
E2 + NaCl 
E 2 + l g 
E2 + 2g 
E2 + 3g 






















Pituitary PRL content 
Since pituitary PRL content varies during the estrus cycle, as well as during lactation and 
weaning, prepubertal virgin rats were used to study the effects of AN extract on pituitary 
PRL levels and mammary gland development. Perphenazine and sulpiride, which act as a 
selective D2 and Dl receptor antagonist respectively and subsequently affect pituitary 
PRL levels, were used as positive controls. We found a significant increase in pituitary 
PRL content in all treated animals, i.e. E2 + 200 mg, E2 + 400 mg, sulpiride or 
perphenazine compared to that in controls i.e. E2 + NaCl or NaCl alone (Figure 4a). 
Sulpiride and perphenazine treatment led to a twofold increase in PRL content compared 
to AN-treated animals. Oral administration of AN extract led to a significant increase in 
PRL content when given in the presence of E2-priming (Figure 4b). One as well as 2 or 3g 
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AN extract given orally, significantly increased pituitary PRL content compared to saline 
or E2-primed animals, whereas pituitary PRL levels were comparable between treatment 
with 3g AN extract without E2 and saline or E2-priming alone. 
Table 5 Alveoli differentiation in different treatment groups, i.e. the number of alveoli type 1 and 2, and the number of 
cells per alveoli (mean ± SEM), A: absent. 
NaCl 
E2 + NaCl 
E2 + 200 mg 
E2 + 400 mg 
Sulpiride 
Perphenazide 
E 2 + l g 
E2 + 2g 
E2 + 3g 















































In this paper, we report the effects of AN extract on cell proliferation and mammary gland 
development in female virgin rats. The rat mammary gland appears to be an excellent 
model for such studies, although the multiple cell types within the gland make the 
interpretation of the histology very complex. During mammary gland development, TEBs, 
which are only present in nonparous rats, are actively growing into ductal structures that 
differentiate to alveolar buds and lobules. TEBs also regress to form terminal ducts that 
are able to differentiate into lobules during pregnancy and lactation. In this study, AN 
extract stimulated mammary gland development resulting in fewer TEBs, and in more 
lobules as compared to untreated animals, albeit that AN-induced mammary gland 
development was limited in the absence of E2. When AN extract was given 
intramuscularly, TEBs were completely suppressed in the E2-primed, high dose AN-
treated groups indicating that E2 effectively sensitises the gland to pituitary hormones 
(Nagasawa & Yanai 1971). Mammary epithelial response to either perphenazine or 
sulpiride, however, was more robust than that to AN extract. The thickness of the 
extralobular stroma, as well as the stroma between adjacent alveoli was smaller. 
Moreover, the lumen of the alveoli was full of basophilic secretions in association with 
lipid globules very similar to those previously reported in lactating mammary glands 
(Pitelka 1980, Jeffers 1935). However, there was clear heterogeneity between lobules and 
individual alveoli within a lobule indicating that alveolar differentiation was still 
incomplete. Similar heterogeneity was also observed in mammary glands of lactating rats 
(Masso- Welch et al. 2000) despite high levels of circulating PRL during that period. This 
incomplete alveolar differentiation may, to some extent, explain the continuing cell 
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Figure 4 Pituitary PRL content in NaCl control (c) or E2-primed animals treated intramuscularly with AN extract in a 
low (200 mg) or high dose (400 mg) or after treatment with perphenazine (Per) or sulpiride (Sulp) (Panel A). Panel B 
shows pituitary PRL content following oral administration of AN extract in different doses with or without E rpriming 
(Panel B): a: significantly different from control and E2; b: significantly different from AN-treatment (mean ± SEM). 
Mammary cell proliferation as demonstrated by the BrdU labelling index was found to be 
significantly higher in all AN-treated animals compared to control and perphenazine-
treated animals. In the lobular structures, which are known to be the working units of the 
mammary gland, the labelling index was found to increase concomitantly with the 
increased doses in i.m. AN-treated animals. Yet the labelling decreased following oral 
AN-treatment in increasing dose. This can be explained by the fact that the more the 
alveoli were developed in terms of number of cells, the lower the labelling index will be 
(see Table 5). This finding suggests that more cell proliferation can be found in the less 
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differentiated lobules, supporting the idea that AN extract is stimulating mammary gland 
differentiation from the less differentiated structures (TEBs) to the most differentiated 
ones (alveolar structures). Although mammary gland development is the primary 
determinant of milk yield and persistency of lactation (Kim et al. 1998), highly 
proliferative mammary gland has also been suggested to promote development of 
mammary carcinoma (Harwell et al. 2002, Snyderwine 1999, Thompson et al. 1998). In 
contrast, reduction of the highly proliferative terminal end bud (TEB) structures in a 
developing mammary gland by differentiation into alveolar buds and lobules, as reported 
following intramuscular as well as oral treatment with AN extract in this study, has been 
suggested to be protective against mammary carcinoma. Moreover, despite the high 
proliferative index observed, we clearly observed myoepithelial cells surrounding the 
alveoli, whereas their absence would be indicative of invasive carcinoma (Fernig et al. 
1991). We hypothesise that the risk of carcinogenesis is minimal. This assumption is 
supported by the fact that AN extract is traditionally used for induction and stimulation of 
lactation in African women who will certainly undergo more than one pregnancy (Chapter 
2). Women, who have carried at least one full-term pregnancy, have lower circulating 
levels of PRL and a blunted PRL response to the secretagogue (Thordarson et al. 1995, 
Musey et al, 1987). This supports the idea that the risk of mammary carcinoma in African 
women who used AN extract is very low. 
Indeed AN-extract as well as either perphenazine or sulpiride injection led to a significant 
increase in pituitary PRL content. In agreement with earlier studies (Stringer et al. 1990), 
we have shown that this perphenazine-induced PRL increase is associated with mammary 
gland growth response and cell proliferation, particularly in the lobular structures. Since 
PRL is known to induce mammary gland differentiation, the AN-induced increase in 
pituitary PRL levels may, at least in part, indeed explain the mammary gland growth and 
cell proliferation observed in this study. However, it is generally admitted that the 
hormonal environment is altered in parous rats as compared with that in age matched 
virgin animals. Both GH and PRL are significantly reduced after parturition, and thus may 
consequently have inhibitory effects on cell proliferation and lactation. 
Although the variability of the lobuloalveolar development in the non-pregnant rat has 
been found to be strain dependent (Imagawa et al. 1990), the overall pattern of growth and 
differentiation and generation of various morphological structures has been assumed to be 
similar to that in humans. Current literature shows that alveolar differentiation is still 
incomplete during lactation in rats (rev Masso-Welch et al. 2000) and that epithelial cells 
undergo proliferation during that period (Joshi et al. 1986). Finally, AN extract has been 
found to stimulate milk production and PRL release in the rat (Lompo et al. submitted). 
Based on these results and those from the present study, we hypothesise that AN-extract 
can indeed induce milk production in women. 
Acknowledgements 
The authors would like to thank Henk Schippers, Hans J. Swarts and Renate Winkels 
(Department of Animal Science, Wageningen University) for their skilful technical 
76 
assistance. Also, we would like to thank Karin Slot (Department of Biochemistry and 
Cellbiology, Veterinary Faculty, Utrecht University) for her valuable help with the 
photographs. 
References 
Fernig DG, Smith JA, and Rudland PS 1991 Relationship of growth factors and differentiation in normal and 
neoplastic development of the mammary gland. Cancer Treatment Research 53 47-78. 
Harwell DME, Stacker TE, Xie B, Pennington KL, McComb RD, and Shull JD 2002 Dietary energy 
restriction inhibits estrogen-induced mammary, but not pituitary, tumorigenesis in the ACI rat. 
Carcinogenesis 23 161-169. 
Horseman ND 1999 Prolactin and mammary gland development Journal of Mammary Gland Biology and 
Neoplasia 4 79-88. 
Imagawa W, Bandyopadhyay GK, and Nandi S 1990 Regulation of mammary epithelial cell growth in mice 
and rats. Endocrine Reviews 90 494-523. 
Jeffers KR, 1935 Cytology of the mammary gland of the albino rat I. Pregnancy, Lactation, and Involution 
American Journal of Anatomy 56 257-278. 
Joshi K, Ellis JTB, Hugues CM, Monaghan P and Neville AM 1986 Cellular proliferation in the rat 
mammary gland during pregnancy and lactation Laboratory Investigation 54 52-61. 
Kim SH, Moon YS, Keller WL and Park CS 1998 Compensatory nutrition-directed mammary cell 
proliferation and lactation in rats British Journal of Nutrition 79 177-183. 
Lompo-Ouedraogo Z, Van Der Heide D, Van Der Beek EM, Swarts JJM Mattheij JAM, and Sawadogo L 
Effect of aqueous extract of Acacia nilotica ssp adansonii on milk production and prolactin release in the 
rat, submitted to Journal of Endocrinology 
Masso-Welch AP, Darcy MK, Stangle-Castor NC and Ip MM 2000 A developmental atlas of rat mammary 
histology Journal of Mammary Gland Biology and Neoplasia 5 165-185. 
McGinley JN, Knott KK and Thompson HJ 2000 Effect of fixation and epitope retrieval on BrdU indices in 
mammary carcinomas Journal of Histochemistry & Cytochemistry 48 355-362. 
Musey VC, Collins DC, Musey PI, Martino-Saltzman D and Preedy JRK 1987 Long term effects of a first 
pregnancy on the secretion of prolactin New England Journal of Medicine 316 229-234. 
Nagasawa H and Yanai R 1971 Increased mammary gland response to pituitary mammotropic hormones by 
estrogen in rats Endocrinologica Japonica 18 53-56. 
Pitelka DR 1980 General morphology and histology of adult gland, In: The mammary gland, Plenum Press, 
New York, 944-965. 
Russo IH and Russo J 1996 Mammary gland neoplasia in long-term rodent studies Environmental Health 
Perspectives 104 938-967. 
Russo IH and Russo J 1978 Developmental stage of the rat mammary gland as determinant of its 
susceptibility to 7,12-dimethylbenz[a]anthracene Journal of the National Cancer Institute 61 1439-1449. 
Sawadogo L and Houdebine LM 1988 Induction de la synthese de caseine-B dans la glande mammaire de 
rates traitees par des extraits de plantes, Comptes Rendus de I'Academie des Sciences Paris 306 167-172. 
Snyderwine EG 1999 Mammary gland carcinogenesis by 2-amino-l-methyl-6-phenylimidazo[4,5-b]pyridine 
in rats: possible mechanisms Cancer Letters 143 211-215. 
Shyamala G 1999 Progesterone signaling in mammary gland morphogenesis Journal of Mammary Gland 
Biology and Neoplasia 4 89-104. 
77 
Abstract 
In view of our previous reports that AN extract can stimulate pituitary PRL synthesis and 
release, as well as mammary gland development and milk production, experiments were 
performed to determine the mechanism of action. To this end virgin (nulliparous) adult 
females as well as parous females at 7, 14 and 21 days following weaning of their pups 
were used. CB154, a potent DA agonist, was used to suppress pituitary PRL synthesis and 
release in adult virgin female rats prior to oral administration of AN extract. Plasma and 
pituitary PRL as well as mammary gland development and differentiation were examined 
following BrdU immunocytochemical staining. Also, detailed histological examination of 
the mammary gland during involution was performed. 
Plasma and pituitary PRL levels were significantly increased in both AN extract and 
sulpiride treated females with a concomitant lobulo-alveolar development with basophilic 
secretion in the lumen of alveoli. Prior treatment with CB154 significantly lowered plasma 
and pituitary PRL levels compared to control, but did not suppress PRL synthesis and 
release completely. A significant increase of pituitary PRL was still observed in the group 
treated with 3 g AN + CB154, although plasma PRL levels were not significantly altered. 
Moreover, treatment with a low dose of 550 mg AN orally was not sufficient to alter either 
plasma or pituitary PRL concentrations. This suggests that the dosage of CB154 used was 
sufficient to block PRL synthesis and release after 2 days of treatment. The increase in 
PRL levels observed after the high dose of AN extract may likely be due to a direct effect 
of the extract on the level of the pituitary. These findings suggest that AN extract acts 
through the hypothalamus-pituitary system to stimulate PRL synthesis and release. Yet, 
other local factors may also contribute to the observed mammary gland development 
following combined AN + CB-treatment, as suggested by the higher incidence of BrdU 
positive cells in the surrounding stroma of the mammary epithelial cells. 
Introduction 
The endocrine system synchronises developmental and functional differentiation of 
reproductive organs in mammals. In rats, several substances have been reported to 
influence mammary gland development from puberty until the end of lactation: estrogen 
(E2) (Sivaraman et al. 2001, Couse & Korach 1999, Anderson et al. 1998, Fendrick et al. 
1998, Shyamala 1997, Silberstein et al. 1994, Haslam 1988, Daniel et al. 1987), 
progesterone (P) (Sivaraman et al. 2001, Shyamala 1999, Robinson et al. 1995), prolactin 
(PRL) (Gallego et al. 2001, Flint et al.\991, Travers et al. 1996), growth hormone (GH) 
(Gallego et al. 2001, Sejrsen et al. 1999, Flint et al. 1997, Travers et al. 1996, Nandi et al. 
1959, oxytocin (OX), thyroid hormones (TH) (Vonderhaar & Greco 1979), 
glucocorticoids (GLC) (Feng et al. 1995) and insulin (INS) (Hadsell & Bonnette 2000, 
Deeks et al. 1988). Whereas E2 and P are primarily responsible for mammary gland 
development and branching, PRL is essential for alveologenesis and functional 
differentiation (Brisken et al. 1999). However, the exact contribution of each of these 
hormones during different stages of development remains to be clarified. Some reports 
show that E2, P, PRL, GH and TH are essential for ductal elongation, branching and 
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alveolar budding (Vonderhaar & Greco 1979, Horseman 1999), and that PRL, GH, TH, 
OX and INS are required for complete lobulo-alveolar development, milk synthesis, milk 
secretion and maintenance of lactation. Although some of these hormones (E2, P, PRL, 
GH, and OX) may have more inductive effects, others (TH, GLC, and INS) have been 
reported to have permissive effects, although direct effects on mammary gland can also 
occur. PRL plays a crucial role in stimulating milk synthesis and secretion. This hormone 
is responsible for direct stimulation of synthesis within the epithelial cell, and also indirect 
stimulation of the proliferation of the secretory cells. Most studies have pointed out its 
essential role in the proliferative phase of alveologenesis in rodents. PRL is a polypeptide 
hormone produced primarily in the pituitary, but numerous extra-pituitary synthesis sites, 
including the mammary gland, have recently been reported. Pituitary PRL release is 
predominantly regulated by PRL inhibiting factors (PIF), the most important being 
dopamine (DA), released from the hypothalamus. The regulatory system of the production 
of PRL from the extra-pituitary sites is still unclear. 2-bromo-a-ergocriptine (CB154), a 
potent selective D2 agonist, inhibits the synthesis and release of pituitary PRL but not of 
extra-pituitary PRL. On the other hand, numerous factors stimulate pituitary PRL 
synthesis and release, such as Ej and sulpiride, a potent Dl receptor antagonist. Our 
previous report shows that extracts of Acacia nilotica ssp adansonii can effectively 
stimulate pituitary PRL synthesis and release, mammary gland development and 
differentiation, and milk production in rats. A question remaining unanswered thus far is 
how AN stimulates mammary gland differentiation: as a consequence of an effect on 
pituitary PRL synthesis and release, and/or through a direct effect on the mammary gland 
itself. To address this issue, we have used CB154, a potent DA agonist, to suppress 
pituitary PRL synthesis and release in adult virgin female rats before treatment with AN 
extract. Plasma and pituitary PRL levels as well as mammary gland development and 
differentiation were examined. Animals treated with sulpiride were used as positive 
controls. In addition, the effect of prolonged AN administration on mammary gland 
development and involution was studied in lactating rats immediately after weaning of 
their pups. 
Materials and methods 
Animals 
Wistar virgin rats were obtained from IFFA-CREDO, France. They were kept under 
controlled illumination (lights on from 6:00 h to 18:00 h) at 22-28° C and had access to 
pelleted food and tap water ad libitum. Females were weighed daily. 
Experiment I 
Twenty-four virgin female rats of 90 days old were divided into 4 groups. Two groups 
were treated orally with either 2 ml NaCl 0.9% (control = Ctr) (n=6) or 550 mg AN 
extract/kg BW/2 ml NaCl 0.9% (AN) (n=6) twice daily for 5 consecutive days, 
respectively. The remaining two groups were treated subcutaneously with bromocriptine 
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(CB154) at a dose of 4.5 mg/kg BW/0.25 ml ethanol 70% twice daily for 2 consecutive 
days. Subsequently, they were treated orally with either 2 ml NaCl 0.9% (CBCtr) (n=6) or 
550 mg AN extract /kg BW/2 ml NaCl 0.9% (CBAN) (n=6) twice daily for 3 consecutive 
days. The 6th day, all animals were anaesthetised with ether and sacrificed by decapitation. 
Pituitaries were collected for PRL extraction as described previously (Chapter 4). The two 
inguinal mammary glands were removed and immediately fixed in alcoholic Bouin. After 
dehydration in a graded series of ethanol and xylene, mammary glands were embedded in 
paraffin. Paraffin sections (5 um) of the mammary glands were collected and stained with 
Harris' haematoxylin and eosin, and examined under a light microscope. 
Experiment II 
Thirty virgin adult females were divided into 5 groups. Two groups were treated orally 
with either saline (Ctr) or 3 g AN (AN) extract/kg BW for 5 consecutive days. The third 
group was treated subcutaneously with 20 mg sulpiride (Sul) /kg BW for 5 consecutive 
days. The last two groups were first treated subcutaneously with 4.5 mg CB154/kg BW for 
2 consecutive days and subsequently treated orally with either 3 g AN extract/kg BW 
(CBAN) or saline for 3 consecutive days (CBCtr). 
The sixth day, all animals received 5 mg BrdU/kg BW i.p., 2 hours before sacrifice. 
Animals were anaesthetised with ether and sacrificed by decapitation. Blood samples were 
taken and the inguinal mammary glands were removed, and subsequently frozen for 
further histological and immunocytochemical staining. The pituitary was removed and 
store at -20° C for PRL extraction. Plasma and pituitary PRL were determined as described 
previously. 
Experiment III 
Twenty-five females were used immediately after weaning of their pups for this 
experiment. A first group of pregnant females (n = 7) was orally administered a daily dose 
of 560 mg AN extract, starting one week before parturition (ANW1). The other two 
groups (n = 6 each) were orally given either 280 mg (AN) or 560 mg AN (ANW2) extract, 
starting the second day of lactation. The last group (n = 6) received saline (Ctr) over the 
entire period of the experiment. 
On days 7, 14, and 21 after weaning of their pups, two females of each group were 
injected with 5 mg BrdU/kg BW 2 hours before sacrifice. Animals were anaesthetized 
with ether and sacrificed by decapitation; blood samples were collected for determination 
of PRL concentrations. The inguinal mammary glands were removed and subsequently 
frozen for immunocytochemical (ICC) staining. The pituitary was removed for prolactin 
extraction. Plasma and pituitary prolactin were determined as described previously. 
Histology of the mammary gland 
Immunocytochemistry for BrdU was performed on unfixed frozen mammary glands from 
rats, collected from animals in experiments II and III as described previously and stained 
according to McGinley et al. (2000) with some modifications (Chapter 5). Also, the 
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manual counting procedure was similar to that described previously (Lompo et al. chapter 
5). Mammary gland differentiation was assessed according to the criteria of Russo and 
Russo (1978, 1996). 
On day 6, mammary glands from the animals in experiment I were removed and 
immediately fixed in alcoholic Bouin. After dehydration in a graded series of ethanol and 
xylene, mammary glands were embedded in paraffin. Paraffin sections (5 /urn) of the 
mammary glands were sliced, dried and stained with Harris' haematoxylin and eosin. 
Mammary gland differentiation was described following light microscopic evaluation. 
Statistical Analysis 
Statistical evaluation of data involved ANOVA followed by Bonferroni and Scheffe test to 
identify differences between groups. P<0.05 was considered to be significant. 
Results 
Plasma and pituitary PRL content 
Treatment with CB154 alone significantly decreased plasma PRL levels compared to the 
control group (P< 0.05) (Figure 1). A significant increase in plasma PRL levels was 
observed in the sulpiride and 3 g AN-treated animals compared to the control and CB154 
treated animals (P<0.05). No significant difference was found between CB154 (1.45 ± 
0.09 ng/ml) and CB154 + 3 g AN (2.49 ±0.12 ng/ml) -treated animals, albeit that a slight, 
non-significant increase in PRL level was observed in the latter group as compared to 
CB154 alone. Plasma and pituitary changes in PRL were highly comparable in magnitude. 
Again, pituitary PRL content in animals treated with either sulpiride or 3 g AN extract 







Sulp T3g CB+T3g 
Figure 1 Plasma PRL concentration (ng/ml) in adult virgin female rats following different treatments: C: saline control, 
CB: bromocriptine, Sulp: sulpiride, T3g: AN extract, CB+T3g: bromocriptine followed by AN extract. 
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difference between the 560 mg AN-treated animals and control animals (data not shown). 
Treatment with 3 g AN extract after CB154 treatment significantly increased PRL content 
compared to that observed in the CB154 treated group, although no significant change was 
found compared to the control group. After weaning of their pups, plasma PRL levels 
gradually declined in the Ctr group to reach a basal level around day 21 (Figure 3). PRL 
levels in the 560 mg AN-treated animals were still relatively high at day 14 as compared 
to that observed in Ctr animals. Pituitary PRL was also found to markedly decline after 
weaning in all animals, although the decrease in time after weaning, especially in the AN-
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Figure 2 Pituitary PRL content (ng/mg tissue) in adult virgin female rats following different treatments: C: saline 



















Figure 3 Plasma 
pups for control ( 
Day 14 
T280mg T560mg 
PRL concentrations (ng/ml) in adult virgin female rats on 7, 14 and 21 days after weaning of their 
c), low dose (T280 mg) and high dose (560 mg) of AN extract administered orally. 
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Mammary gland development and differentiation 
Mammary glands of the control group showed bare duct systems with few alveolar buds, 
within extensive connective tissue (Figure 4A). More lobulo-alveolar structures filled with 
basophilic secretions were found in AN-treated animals (Figure 4B) than in the control 
and in the CB154-treated groups (Figures 4C-D). Large vacuoles were present in some of 
the cells. Mammary glands of animals treated with CB154 showed an ill-defined alveolar 
structure with very dark nuclei in the epithelial cells (Figure 4C). Treatment with 
ANextract after CB154 (Figure 4D) did not reverse the situation, albeit that some mitotic 
cells were seen (arrowhead). 
Detailed histological examination of mammary glands during involution was also 
performed. Mammary glands from both control (Figures 5A and 5C) and AN-treated 
animals (Figures 5B and 5D) showed clear lobulo-alveolar structures within the stromal 
tissue. Compared to control animals, less stromal tissue was seen surrounding lobulo-
alveolar structures from AN-treated animals (see Figures 5A-B). Yet, the mammary gland 
of both AN-treated and control animals at day 21 appeared to be very similar (Figures 5C-
D). 
To further understand the effect of AN extract on mammary gland differentiation, BrdU 
staining was performed to identify proliferating cells. BrdU positive cells were clearly 
visible as middle to dark brown stained cells. Quantification of BrdU positive cells 
(expressed as the number of BrdU cells / total cells within the structure) showed a higher 
proliferating index in AN-treated animals as compared to that in control animals. 
However, no BrdU positive cells were observed in mammary epithelial of rats receiving 
CB154 alone or with AN extract, albeit that in the latter case, a larger number of BrdU 
positive cells was found in the stromal tissue surrounding the mammary epithelium 
(Figure 4E). 
Discussion 
In this report, the effect of 2-bromo-a-ergocriptine (CB154), a selective dopamine D2 
receptor agonist, on PRL synthesis and release and mammary gland development was 
studied. CB154-treated animals were compared to AN-treated animals, and to control 
animals treated either with saline or sulpiride alone. Extensive lobulo-alveolar growth with 
functional development of the mammary gland occurred after both sulpiride and AN-
treatment in adult virgin cycling female rats. Mammary gland development is known to 
differ throughout the cycle with the less differentiated mammary gland consisting of ducts 
and TEBs, and fewer alveoli being observed during diestrus as compared to other days of 
the cycle. Histological examination of the mammary glands showed a comparable image 
in our control animals to that reported previously in mammary glands from diestrus 
animals (Chapter 4), although the mammary gland of CB154-treated animals also showed 
apoptotic cells with dark nuclei. 
Plasma and pituitary PRL levels were significantly increased in both AN extract and 
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Figure 4 Photographs showing BrdU 
immunocytochemical staining of mammary 
glands of virgin adult female rats following 
control (panel A), AN (panel B), 
bromocriptine (CB, panel C) or combined CB 
+ AN-treatment (panels D and E). Panel E 
shows details of stromal tissue surrounding 
mammary tissue from a rat treated with CB + 
AN. Magnification 400x. Teb: terminal end 
bud, Dc: duct, S: milk secretion, Pt: stromal 
^ tissue; arrowheads point at BrdU positive 
cells. 
reported previously (Chapter 5). Treatment with CB154 significantly lowered plasma and 
pituitary PRL compared to that of control animals. A significant increase of pituitary PRL 
content compared to CB154 treatment alone was observed in the group treated with 3 g 
AN + CB154 although no significant increase was noticed in plasma PRL concentrations. 
Oral administration of a low dose of 560 mg AN after CB154 was not efficient in 
increasing either plasma or pituitary PRL. This suggests that the dose of 4.5 mg CB154/kg 
BW was sufficient to block PRL synthesis and release after 2 days of treatment, and that 
the increase observed after the high dose of AN extract may likely be due to an effect of 
the extract. These findings suggest that AN extract acts, at least in part, through interaction 
with the hypothalamo-pituitary system to stimulate PRL synthesis and release. Yet, also 
other factors are likely to be involved, as suggested by the higher incidence of BrdU 
positive cells in the surrounding stroma of mammary epithelial cells. 
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Figure 5 Photographs showing BrdU immunocytochemical staining of mammary glands of parous female rats after 
weaning of their pups of control animals (panels A, C and E) and following continuous treatment with AN extract 
(panels B, D and F). Panels A and B show the presence of lobulo-alveolar structures in haematoxylin-eosin stained 
sections of the mammary gland at 7 days after pup weaning at a low magnification (lOOx). Panels B and D show 
representative examples of alveolar structures from material following BrdU staining at 14 days after pup weaning, 
magnification 400x. Note the abundance of BrdU positive cells in the lobuli of AN-treated animals. Panels E and F show 
comparable degrees of differentiation of mammary glands in control and AN-treated animals at 21 days after pup 
weaning in BrdU stained sections, magnification 400x. Arrowheads point at BrdU positive cells in the tissue, L: lobule, 
Adp: adipose tissue, Pt: stromal tissue, Dc: ducts, S: milk secretion in the lumen. 
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Basically, treatment with E2 stimulates both PRL and GH release; PRL either alone or 
with E2 has been found to stimulate progesterone production. All these hormones are 
known to stimulate mammary growth and differentiation. Indeed, CB154 may act on the 
D2 receptors of the pituitary gland to inhibit PRL secretion but it does not alter levels of 
extra-pituitary PRL and PRL of mammary gland origin. The biological effects of PRL are 
presumably mediated by the PRL receptor (PRL-R) that is a member of the cytokine 
receptor super family (Kelly et al. 1993). Therefore, it is feasible to suggest that AN 
extract could also act directly on the mammary gland by stimulating either PRL-R or by 
activating mammary cell activity. The latter may be achieved by increasing amino acid 
transport since a decrease of milk yield, with a concomitant decrease in milk protein and 
lactose, has been reported in lactating rats treated with CB154. Most likely, all these 
events may occur concurrently as evidenced by the presence of basophilic secretions in the 
lumen of alveoli of mammary glands from rats treated with CB154 + extract. 
Likewise, Euphorbia hirta has also been found to stimulate B-casein secretion in rat 
mammary glands following CB154 treatment (Sawadogo et al. 1988). 
These results strongly suggest that AN extract stimulates milk production, and mammary 
gland development and differentiation by inducing PRL synthesis and release at the level 
of the pituitary, or via inhibition of stimulation of other pituitary hormones. These in turn 
stimulate mammary growth and differentiation. In addition, AN extract may also act 
directly on the mammary gland itself by stimulating the synthesis of milk components 
directly or indirectly, although further research will be necessary in order to elucidate the 
mechanism of action of AN extract on mammary gland tissue directly. 
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The aim of this study was to document plants used by women for the treatment of 
lactation-related defects, to investigate the biological activity of the plants used for 
induction and stimulation of lactation, and finally to assess the underlying mechanism of 
action in a rat model. 
Lactation is an essential phase during development since young are very immature at birth 
and totally dependent on their mother's milk for a varying time thereafter. Milk is 
synthesised within the cell lining of the mammary gland alveoli. Milk is a complex 
product consisting mainly of water, sugars, lipids (mainly triglycerides), proteins (e.g. 
casein, lactalbumin) as well as monovalent and divalent cations and, most interesting, 
antibodies. In the Western world, survival of newborns does not rely solely on the capacity 
of the mother to lactate because of the tremendous availability of artificial milk. In 
developing countriesmother's milk is even more important for survival of the newborn 
because artificial milk is not available or out of reach for the majority of women. Although 
99% of the women in Burkina Faso that gave birth are breast-feeding, infant morbidity and 
mortality are still high. Next to their nutrients, colostrum and milk contain maternal 
antibodies for the newborn, serving as important protective agents against infections. 
Deviations in maternal milk quantity and/or quality early after birth might therefore affect 
infant well-being and development, which later determines the infant's resistance to 
infections. With limited access to modern milk alternatives, African women with milk 
production deficiencies traditionally use plant extracts to induce milk production or to 
increase milk yield. 
In chapter 1, a definition of African Traditional Medicine and its implications for the 
practice of breast-feeding in African communities are reported. In addition, a review of 
mammogenesis, lactogenesis, and related hormonal regulation is reported. Finally, the 
possible causes of disruption of lactation are briefly discussed. 
From this review, it appears as if lactation is a result of long physiological processes 
occurring in the mammary gland from pregnancy until the day of parturition, and that its 
success depends on mammary epithelial cell proliferation and differentiation, and on PRL 
levels for stimulation of synthesis of milk components. The effect of the nutritional state 
of the mother on milk yield, however, is still unclear. 
Chapter 2 describes a field study carried out between 1997 and 1999 to document plant 
use for the treatment of lactation-related defects within five provinces of Burkina Faso. 
From the literature, floristic and ethnobotanical aspects of African plants with therapeutic 
properties have been extensively studied. However, much information regarding the 
number of cases reported, the number of people who have used this medication as well as 
the biological activities is missing. 
During this study, questions were asked and discussions were carried out with 296 people, 
including traditional healers (34), village elders (45) and women (217) supposedly using 
those prescriptions. Transmission of knowledge is essentially oral, from father to son or 
from mother to daughter: 89% of the informants had received their knowledge from their 
parents. Ninety species of plants with medical use belonging to forty families are listed 
together with their local names, the plant parts used for treatments, the number of times 
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reported by the informant, and the number of women that used this prescription. It appears 
that all women that were interviewed during this inventory actually used plant medication 
during their lactation period. This indicates a real existence of lactation-related defects 
and/or more cultural practices. The latter, however, seems quite unlikely since 40% of the 
women have used plant medication for the treatment of agalactia or hypogalactia, and at 
least 10 % have stopped an ongoing lactation because of mastitis or death of the infant. 
The number of species reported gives an overview of the widespread use of plants in basic 
health care as well as of the prevalence of a given disorder; the number of people that used 
this medication may be of great interest for statistics on the state of health among the 
general population. It should be noted that not all the plants reported by the informants are 
used by the women. This discrepancy could be due to the fact that, for the greater part, 
plants used for induction or stimulation of lactation were given in a form of mixture of at 
least two plants. This survey pointed out seven species including Pennisetum americanum, 
Vitellaria paradoxa, Cadaba farinosa, Acacia nilotica var adansonii, Leptadenia hastata, 
Capsicum frutescens, and Crateva adansonii widely used by women in such a variety of 
recipes. However, the unsolved question is which plant or plants contain active 
components? It seems likely that some of the plants in a given treatment mixture actually 
induce or stimulate lactation, while other plants in the same mixture may be added to 
inhibit the possible toxicity of active plants. 
Pennisetum americanum, Vitellaria paradoxa, Cadaba farinosa, Capsicum frutescens, 
Crateva adansonii, and Leptadenia hastata are commonly used in human alimentation, 
albeit that the latter is forbidden for pregnant women, what might be related to its abortive 
effects as reported by Noumi and Tchkonang (2001). 
In contrast, Acacia nilotica var adansonii appeared to be widely used and frequently 
associated with other plants in other parts of Burkina Faso as well as in some other 
countries, for the treatment of a wide variety of diseases. Studies concerning the 
ethnopharmacology, phytochemistry and toxicology of Acacia nilotica species as reported 
in chapter 3, do not clearly specify the variety used. From Kerharo and Adams (1974), it 
appears as if Acacia nilotica var. adansonii (Guill. et Perr.) O. Ktze is a thorny tree of up 
to 10-12 m of length, with a dark grey bark colour, green-grey leaves and golden flowers 
and that three species that resemble it in foliage and inflorescence have nearly the same 
systematic characteristics. Consequently, this makes the systematic characterization of A. 
nilotica species rather confusing. Nevertheless, people in the villages are able to identify 
these 3 species very reliably. The literature review confirmed A. nilotica's multiple 
therapeutic properties, as all parts of the tree are used in folk medicine. Despite its 
widespread therapeutic properties reported, little is known about its actual 
pharmacological mechanisms. In view of the traditional information that AN could induce 
and/or stimulate lactation in women, experiments were performed as described as in 
chapters 4 and 5. 
In chapter 4, the effects of an aqueous extract of AN on milk production and PRL 
synthesis and release were investigated. Lactating female rats were given a low or high 
dose of AN extract orally during 13 consecutive days starting on day 2 of lactation, as 
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compared to a control group treated with saline. Milk yield was measured daily through 
pup weight and pup weight gain (Morag et al. 1975, Sampson et al. 1984, Kamani et al. 
1987, Kim et al. 1998). This study demonstrated that animals treated with either a low or a 
high dose of AN extract produced significantly more milk associated with an increase in 
pup growth, as compared to that in control animals, and that milk yield appeared to be 
significantly stimulated approximately 24 hrs after start of the treatment. AN extract 
induced milk production in a dose-dependent manner, although the pups' growth rates of 
the low dose AN-treated animals were similar to that of the high dose group. This 
discrepancy may be explained by the fact that milk yield is governed by suckling 
frequencies, which depend on the energy content of the mother's milk (Perez-Escamilla et 
al. 1995, Prentice et al. 1986, Villalpando et al. 1999). 
To investigate the effect of AN on PRL synthesis and release, experiments were 
performed in peri-pubertal and adult virgin female rats. PRL is known to vary during the 
estrus cycle as well as during lactation and weaning. A strong relation between extract 
administration and PRL release after "acute" as well as "chronic" treatment has been 
observed in the cycling female treated intravenously. PRL synthesis was also stimulated 
by AN extract in both adult and pre-pubertal animals, albeit that in the latter group, E2-
priming was needed for an efficient effect. This strongly suggests that the extract had a 
specific effect on PRL-synthesis/secretion under certain physiological conditions, which is 
consistent with its traditional use during lactation. 
PRL is known to stimulate milk synthesis and secretion. However, in the last decades, 
research has also shown a relationship with breast carcinogenesis; i.e. an increase in PRL 
synthesis and release may increase susceptibility to mammary carcinomas (Venugopal et 
al. 1999). In order to provide more insight into the effects of AN extract on mammary 
gland development and differentiation, experiments were performed as reported in 
chapter 5. In that chapter, we investigate the effect of AN extract on cell proliferation 
using bromodeoxyuridin (BrdU). BrdU is an analogue of thymidin that is incorporated into 
proliferating cells. 
To this end, adult as well as virgin female rats were treated with AN extract, either oral or 
i.m., with or without prior E2-priming. Perphenazine and sulpiride were used as positive 
controls. Before sacrifice, a subcutaneous injection of BrdU was given. Pituitaries were 
collected for PRL content determination. Mammary gland tissue was removed and 
processed for BrdU immunohistochemical staining. The BrdU labelling index was 
calculated from the total number of epithelial cell per unit of surface area. 
The treatment with AN extract resulted in a significant increase of PRL synthesis, 
associated with increased lobulo-alveolar structure development, filled with basophilic 
secretions and lipids globules compared to control groups. Mammary gland from either 
perphenazine or sulpiride-treated groups showed a significant increase in pituitary PRL 
content, associated with highly developed alveolae filled with basophilic secretions and 
lipids globules, very similar to what has been reported for the lactating mammary gland 
(Pitelka 1980, Jeffers 1935). 
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Terminal end buds (TEBs) were completely suppressed in the E2-primed, high dose AN-
treated groups when treatment was given intramuscularly. Mammary cell proliferation was 
found to be significantly higher in all AN-treated groups compared to that of control 
animals. This study shows that the BrdU labelling index was significantly higher for the 
lobular structures than for the ductal structures in all AN-treated animals, indicating more 
proliferative activity in the lobular unit, which indeed is the working unit of the mammary 
gland (Stringer et al. 1990). In this chapter, we have shown that AN extract stimulates 
mammary gland growth and differentiation from the least differentiated structures (TEBs) 
to the highly differentiated ones (alveoli), and may thus have a stimulating effect on milk 
production. 
Mammary gland development is the primary determinant of milk yield and persistency of 
lactation (Kim et al. 1998), as said highly proliferative mammary gland may promote 
development of mammary carcinoma (Harwell et al. 2002, Snyderwine 1999, Thompson 
et al. 1998). On the other hand, reduction of the highly proliferative terminal end bud 
(TEB) structures in a developing mammary gland by differentiation into alveolar buds and 
lobules as reported in this study, has been suggested to be protective of mammary 
carcinoma. Moreover, it has been reported that women who have carried out at least one 
pregnancy to term have lower circulating levels of PRL and a blunted PRL response to a 
secretagogue (Musey et al. 1987). Based on the above we believe that the risk of 
mammary carcinogenesis related to the use of AN extract is minimal, also since we have 
previously (Chapter 2) reported that AN extract is traditionally used for induction and 
stimulation of lactation in African women who will certainly undergo more than one 
pregnancy. Although the variability in the degree of lobulo-alveolar development in non-
pregnant rats has been found to be strain-dependent (Imagawa et al. 1990), the overall 
pattern of growth and differentiation and generation of various morphological structures 
shows striking similarities to that of humans. It has been reported that alveolar 
differentiation is still incomplete during lactation in the rat ( Masso-Welch et al. 2000), 
and that epithelial cells are undergoing proliferation during that period (Joshi et al. 1986). 
Based on the fact that AN extract has been found to stimulate milk production and PRL 
release in rats (Chapter 4), we hypothesise that AN extract can indeed induce milk 
production in women. 
Chapter 6 deals with the effects of AN extract on mammary gland growth and 
differentiation. Are these processes only attributable to a response to the sustained 
elevation of PRL synthesis and release or rather, stemming from a direct effect on the 
mammary gland? As dopamine (DA) is the main inhibiting factor of PRL synthesis and 
release from the pituitary, bromocriptine (CB154), an agonist of DA was used to suppress 
PRL synthesis and release in cycling female rats. Plasma and pituitary PRL, mammary 
gland development and differentiation were examined after AN-treatment. Animals treated 
with sulpiride were used as positive controls. Plasma and pituitary PRL levels were 
significantly increased in both AN extract and sulpiride-treated animals with a 
concomitant lobulo-aveolar development with basophilic secretions in the lumen of the 
alveoli. Treatment with CB154 indeed significantly lowered plasma and pituitary PRL 
levels, compared to control but did not suppress PRL synthesis and release completely. A 
significant increase of pituitary PRL was observed in the group treated with 3 g AN + 
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CB154 as compared to CB154 alone, although no significant change was found in plasma 
PRL. Yet, oral administration of a low dose of 560 mg AN was not insufficient to increase 
either plasma or pituitary PRL levels. This suggests that the dose of 4.5 mg CB154/kg BW 
was sufficient in blocking PRL synthesis and release after 2 days of treatment, and that the 
increase observed after the high dose of AN is likely to be an effect of the extract. 
These findings suggest that AN extract acts through the hypothalamo-hypophysis-axis in 
stimulating PRL synthesis and release, although other factors are likely to be involved as 
well. Indeed, CB154 acts on the D2 receptors of the pituitary gland to inhibit PRL 
secretion. Secretion of PRL, however, is not limited to the pituitary as numerous extra-
pituitary sites of PRL expression including the mammary gland have been reported 
recently. Apart from the possibility that AN extract might act through stimulating the 
release of other hormones (since treatment with E2 stimulates both PRL and GH release; 
PRL either alone or with E2 stimulates progesterone production, and these are all known to 
stimulate mammary growth and differentiation) it could be that AN extract acts directly on 
the mammary gland by stimulating either PRL-R or by activating mammary cell activity 
by increasing amino acid transport. Most likely, all of these events may occur 
simultaneously, as evidenced by the presence of basophilic secretion in the lumen of 
alveoli of mammary gland from rat treated with CB154 + extract. Likewise, Euphorbia 
hirta has noted to stimulate B-casein secretion in rat mammary glands after CB154-
treatment (Sawadogo et al. 1988). Prolactin plays a key role in maintaining lactation in rat. 
Moreover, suppressing lactating in rat by the use of CB154 led to a decrease of 57% of 
milk yield with a concomitant decrease in milk protein and lactose. 
These results indicate that the AN-extract indeed act by stimulating the synthesis and the 
release of PRL and probably other pituitary hormones. In turn, these hormones stimulate 
the mammary growth and differentiation. More likely, AN-extract may act directly on the 
mammary gland by stimulating the synthesis of milk components, although further 
research is needed to elucidate the possible mechanisms of action of AN extract. 
More research on the effect of AN-extracts on milk secretion and yield is certainly needed 
before the findings from this research can be used to improve traditional practices related 
to the management of milk production in the human. Work may also have to be conducted 
on unveiled other possible positive or negative effects of AN extracts. However, from this 
study, the fact that a traditional practice has been demonstrated to be scientifically sound, 
improves the credibility of traditional medicine in general and the traditional practices 
during lactation in particular. It is also opens a tremendous array of possibilities for 
research on tradtional health care practices and traditional use of plants. As pointed out by 
our survey, there are a large number of plants used to solve various health-related 
problems. Thus, it seems reasonable to (i) suggest the development of specific research 
programs on the subject in the near future, and to (ii) promote the inclusion of the 
traditional medicine in national health care policies and programs. 
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In dit proefschrift worden extracten van planten beschreven, welke worden gebruikt door 
vrouwen in Burkina Faso voor de behandeling van problemen met de lactatie. De 
biologische activiteit van planten voor de inductie en stimulatie van de lactatie is 
onderzocht en met name het onderliggende mechanisme van de activiteit is van een extract 
is nader onderzocht in de rat. 
De lactatie-periode is een essentiele fase omdat een baby erg immatuur is direct na de 
geboorte en daarom totaal afhankelijk van moedermelk in de periode daarna. Melk wordt 
gesynthetiseerd in de cellen die rondom de alveoli van de melkklier liggen. Melk is een 
complex product bestaande uit voornamelijk water, melksuikers, vetten (voornamelijk 
triglyceriden), melkeiwitten (caseinen, lactalbumine), mineralen en immunoglobulinen. In 
de westerse wereld is de overleving van de nieuwgeborene niet direct afhankelijk van het 
vermogen van de moeder om melk te produceren, aangezien er een groot aanbod is van 
commerciele kunstmelk. In ontwikkelingslanden daarentegen, is moedermelk essentieel 
voor de overleving van de nieuwgeborene, omdat kunstmelk of niet beschikbaar is of 
buiten de financiele vermogens van de familie ligt. Ondanks dat 99% van de vrouwen in 
Burkina Faso borstvoeding geven, is de morbiditeit en mortaliteit van de jonge kinderen 
nog steeds erg hoog. Colostrum en melk hebben een heel belangrijke functie bij de 
immunologische bescherming tegen infecties. Een snel optredend tekort aan 
moedermelkkwantiteit en -kwaliteit kan het welzijn en de ontwikkeling van een 
nieuwgeborene schaden, waardoor later in het leven problemen met de weerstand tegen 
infecties optreden. Met de gelimiteerde beschikbaarheid van moderne 
moedermelksubstituten gebruiken Afrikaanse vrouwen in geval van problemen met de 
lactatie liever traditioneele plantenextracten om de melkproductie te induceren of te 
verhogen. 
In hoofdstuk 1 zijn de implicaties van de traditionele gebruiken van het borstvoeden in 
deAfrikaanse leefgemeenschap beschreven. Daarnaast wordt een breed overzicht van de 
regulatie van mammogenese, lactogenese en de daartoe benodigde hormonale regulatie 
gegeven. Uiteindelijk worden de mogelijk oorzaken van problemen met de lactatie 
bediscussieerd. 
Met de huidige kermis is het duidelijk dat de lactatie het resultaat is van een lange serie 
fysiologische processen die zich in de melkklier voltrekken van zwangerschap tot aan de 
dag van geboorte en de eerste dagen daarna. De mate van succes van de lactatie is 
afhankelijk van de mate van proliferatie en differentiatie van het melkklierepitheel en van 
het vrijkomen van het hormoon prolactine (PRL) uit de hypofyse, nodig voor de stimulatie 
van de melksynthese. 
In hoofdstuk 2 is een veldstudie in 5 provincies van Burkina Faso beschreven, uitgevoerd 
tussen 1997 en 1999, om te documenteren welke plantenextracten worden gebruikt om 
problemen met de lactatie te behandelen. De ethnobotanische aspecten van deze 
Afrikaanse planten met therapeutische eigenschappen zijn beschreven. Echter het aantal 
vrouwen dat deze medicatie gebruikt en de mate van biologische activiteit van deze 
extracten, zijn onbekend. 
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In Burkina Faso, en ook in verschillende andere omliggende landen, wordt Acacia nilotica 
var adansonii veelvuldig gebruikt, vaak in combinatie met andere planten in de 
behandeling van verschillende ziekten. Echter, uit ethnofarmacologisch, phytochemisch en 
toxicologisch onderzoek is, zoals beschreven in hoofdstuk 3, niet duidelijk welke 
specifieke varieteiten gebruikt worden. Er zijn drie species beschreven met bijna identieke 
systematische karakteristieken, hetgeen de systematiek van Acacia nilotica erg verwarrend 
maakt. Echter, de locale bevolking in de dorpen hebben hier geen enkel probleem mee. 
Gebaseerd op de traditioneele informatie dat een extract van Acacia nilotica var adansonii 
(AN) de lactatie kan induceren en/of stimuleren, zijn experimenten in ratten, zoals 
beschreven in de hoofdstukken 4, 5 en 6, uitgevoerd. 
In hoofdstuk 4 is het effect van een waterig extract van AN op de melkproductie en de 
PRL synthese en afgifte bestudeerd. Lacterende vrouwelijke ratten kregen dit extract in 
een lage respectievelijk hoge dosis oraal toegediend gedurende 13 dagen, te beginnen op 
de tweede dag van de lactatie. De melkgift werd gemeten door de jonge ratjes te wegen en 
de toename in gewicht te berekenen. Uit dit onderzoek werd duidelijk dat de 
moederdieren, behandeld zowel met de lage als met de hoge dosis, significant meer melk 
produceerden en dat hun jongen sneller groeiden dan die van controle moederdieren. De 
toename in melkgift was reeds 24 uur na het begin van de behandeling waar te nemen. 
Het effect van het AN-extract werd ook bestudeerd in peri-pubertale en volwassen 
maagdelijke ratten. Hierbij bleek dat de PRL-synthese en -afgifte bij deze ratten eveneens 
werd gestimuleerd. Bij de peri-pubertale ratten was een korte voorbehandeling met 
oestradiol nodig om het vereiste effect efficient te laten plaatsvinden. Dit suggereert dat 
het extract de PRL-synthese en -afgifte stimuleert tijdens condities die aanwezig zijn 
tijdens de lactatieperiode. 
In hoofdstuk 5 is het effect van het AN-extract op de proliferatie van cellen in de 
melkklier bestudeerd door gebruik te maken van bromodeoxyuridine (BrdU). BrdU is een 
analoog van thymidine dat wordt geincorporeerd in cellen in de S-fase van de celcyclys 
vlak voordat ze celdeling ondergaan. BrdU wordt immunohistochemisch aangekleurd voor 
detectie in histologisch materiaal. 
Volwassen, maagdelijke vrouwelijke ratten werden behandeld met het AN-extract zowel 
oraal als intramusculair, met of zonder voorbehandeling met oestradiol. Een uur voordat 
de dieren werden gedood werd een subcutane injectie met BrdU toegediend. De 
proliferatie van cellen in de melkklier was in alle groepen met AN-extract verhoogd. De 
labelingsindex van BrdU was significant hoger in de lobulaire structuren in vergelijking 
tot in de ductus structuren. Dit suggereert dat de proliferatieve activiteit met name 
gestimuleerd wordt in de lobuli, het melkproducerende deel van de melkklier. 
In hoofdstuk 6 is onderzocht of de effecten van het AN-extract op de groei en 
differentiatie van de melkklier alleen dient te worden toegeschreven aan de gestimuleerde 
PRL-synthese en -afgifte, of dat er ook een direct effect op de melkklier aanwezig is. 
Aangezien dopamine (DA) de belangrijkste remmende factor op de synthese en afgifte van 
PRL in de hypofyse is, werd in de volgende experimenten bromocryptine (CB 154), een 
agonist van DA. Vrouwelijke ratten, behandeld met CB 154, vertoonden inderdaad een 
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verlaging van de gehaltes PRL in plasma en hypofyse. Toediening van een hoge dosis AN-
extract veroorzaakte een stijging van het hypofysaire PRL gehalte maar geen stijging in 
het plasma. 
Deze bevindingen suggereren dat de mogelijkheid aanwezig is dat het AN-extract 
werkzaam is op de hypothalamus-hypofyse as via stimulatie van PRL synthese en -afgifte 
maar dat andere regulerende factoren zeker niet kunnen worden uitgesloten. 
Meer onderzoek naar de effecten van het AN-extract op de melkkwaliteit en -kwantiteit is 
nodig alvorens de beschreven bevindingen kunnen worden toegepast om de traditionele 
gebruiken in de lacterende Afrikaanse vrouw te verbeteren. Ook is verder onderzoek nodig 
om andere eventueel positieve dan wel negatieve effecten van AN-extract te bestuderen. 
Het in dit proefschrift beschreven onderzoek toont aan dat een traditioneel gebruik van een 
plantenextract inderdaad werkt en het beoogde doel heeft, te weten de lactatie te op gang 
te brengen, c.q. te stimuleren. Dit opent perspectieven om onderzoek te verrichten op het 
gebied van het gebruik van traditionele planten in de traditionele gezondheidszorg. Het 
lijkt daarom redelijk om (i) speciale onderzoeksprogramma's te ontwikkelen op deze 
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